M&AAcquisition · Announced
Tend health acquires The doctors
On Tuesday, Tend Health announced an iwi-backed $270 million acquisition of The Doctors from NZX-listed Green Cross Health.
Medical and urgent care
The Seattle edition · 2026
Seattle · Photo: Wikimedia Commons (CC BY-SA 4.0)Life sciencescompanies in Seattle
Platforms & tools, oncology, genomics, immunotherapy, neurology and more: the companies building life sciences in Seattle, Washington, with their founders, funding, team size and business models.
205 company profiles101 with recorded fundingNovember 2026 edition
Recent life sciences business events in Seattle
Funding, M&A, contract wins and launches involving 305 life sciences companies in Seattle, last 24 months: 33 funding rounds · 30 M&A deals · 4 Contracts. Newest first; companies and investors link to their Fliar profiles. Latest event in our news feed: Jun 2026.
M&AAcquisition · Announced
Eli Lilly and Company acquires Curevo Vaccine
Lilly announced a major push into vaccines, including the planned acquisition of Curevo Vaccine for $1.5 billion and other vaccine-developer deals, signaling a new long-term growth…
Vaccine Development
M&AAcquisition · Announced
Eli lilly acquires Curevo Vaccine
Curevo Vaccine has entered into a definitive agreement to be acquired by Eli Lilly.
Biotechnology
M&AAcquisition · Announced
Akamai acquires Lumen
In its own announcement, Akamai said it had acquired assets, including select content delivery customer contracts, from Lumen Technologies.
Telecommunications
M&AAcquisition · Announced
Lumen acquires Alkira
Lumen has announced an agreement to acquire Alkira, a cloud-native, carrier-agnostic networking platform that enables enterprises to design, deploy, and operate connectivity across…
Cloud-native networking platform
M&AAcquisition · Completed
Scantox Group acquires Twinstrand biosciences
most recently acquired the DuplexSeq™ nonclinical genomic safety business from TwinStrand Biosciences.
Contract Research Organization
M&AAcquisition · Announced
Vistria acquires Lumen
Vistria, a middle market private investment firm with deep sector expertise across essential industries, announced the acquisition of Lumen, a technology-enabled Managing General Agent…
Managing General Agent
Contract
At&t · client: Lumen
AT&T’s $5.75 billion acquisition of Lumen’s Mass Market fiber business on Monday.
Telecommunications
FundingSeries B
Tenpoint therapeutics
Innovative eye treatment firm, Tenpoint Therapeutics, has raised $235M in a Series B round with support from Hillhouse Family Office
Investors Hillhouse Family Office
M&AAcquisition · Completed
At&t acquires Lumen
AT&T has completed its acquisition of substantially all of Lumen's Mass Markets fiber business, closing a $5.75 billion all-cash transaction that was first announced last year.
Telecommunications
FundingSeries B
Tenpoint therapeutics
Tenpoint Therapeutics, a biotech developing treatments for age‑related vision loss, secured $235 million in Series B funding to support the U.S. launch of its presbyopia eye drop.
Biotech (vision)
M&AAcquisition · Announced
Qiagen acquires Parse biosciences
In November 2025, Qiagen agreed to acquire Parse Biosciences, a provider of scalable, instrument-free solutions for single-cell research, for an upfront payment of approximately $225…
Single-cell research
Funding
Curi bio
Curi Bio – $10.0M
M&AAcquisition · Announced
Ubs acquires Parse biosciences
Analyst Dan Leonard responded to the quarterly figures, the purchase of Parse Biosciences and the search for a new CEO on Tuesday evening.
M&AAcquisition · Announced
Qiagen acquires Parse biosciences
Qiagen announced Tuesday that it will acquire single-cell sample preparation firm Parse Biosciences for $225 million in cash with up to $55 million in milestones over a multiyear period.
Biotechnology
FundingSeed
Synthesize Bio
Synthesize Bio, a biotechnology company pioneering biological foundation models to simulate the results of gene expression experiments, today announced a $10 million seed round led by…
Biotechnology
Funding
Tend health
Private equity firm Pencarrow and iwi investor Ahuahu Group have invested an undisclosed amount in primary healthcare provider Tend Health.
Investors Pencarrow, Ahuahu Group
Primary Healthcare Provider
FundingPublic offering
Sana biotechnology
Sana Biotechnology, Inc. (Nasdaq: SANA) (“Sana”), a company focused on changing the possible for patients through engineered cells, today announced that it has closed the sale of…
Biotechnology
Funding
Spoke sciences
Spoke Acquisition Corporation (Spoke Sciences), Bethlehem, Northampton County
M&AMerger · Announced
Tuhura biosciences acquires Kineta
Kineta stockholders approved the proposed merger (the "Merger") with TuHURA at Kineta's Special Meeting of Stockholders held today, June 23, 2025.
Biotechnology
M&AAcquisition · Announced
AT&T Inc. acquires Lumen
The Company recently announced an agreement to acquire substantially all of Lumen's Mass Markets fiber internet connectivity business.
Fiber internet connectivity
M&AAcquisition · Announced
Goldeneye acquires Know labs
Goldeneye will acquire a controlling stake in Know Labs through a combination of 1,000 Bitcoin and cash to retire debt and fund operations, valuing shares at $0.335.
Health Care
FundingDirect offering
Aptevo therapeutics
Aptevo expects the gross proceeds from the offering to be approximately $2.0 million, before deducting the placement agent's fees and other estimated offering expenses payable by the…
Biotechnology
M&AAcquisition · Announced
Alcon acquires Aurion biotech
Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced it has acquired a majority interest in Aurion Biotech, Inc.
Cell therapy
Funding
Curevo Vaccine
The Seattle-based firm, Curevo Vaccine, also said that it has raised an additional $110 million from investors led by Medicxi, a London-based venture capital firm, and including OrbiMed,…
Vaccine
FundingSeries A
Tasso
Tasso raised $17M.
Investors Hambrecht Ducera Growth Ventures
FundingSeries B
Amnis
Zurich-based fintech AMNIS Treasury Services (amnis) has completed its Series B funding round, securing CHF 10M (approximately €10.70M) to support its growth.
Fintech
FundingSeries B
Allozyne
Allozyne raised $30M in a Series B round led by MPM Capital, with participation from OVP Venture Partners, Amgen Ventures, ARCH Venture Partners and Alexandria Real Estate Equities Inc.
FundingSeries B
Healionics
Healionics (Redmond, Washington), a provider of tissue regeneration and device bio-integration solutions to healthcare manufacturers, reported raising $2.6 million in a Series B…
Tissue Regeneration and Device Bio-Integration
FundingSeries B
Immune Design Corp
Immune Design Corp. raised $32 million in Series B funding.
Investors Na
Life sciences companies in Seattle, by funding and team
Few life sciences companies in Seattle, Washington publish revenue, so this list compares what is on record instead: recorded equity funding, team size, revenue model, age and stage. The 50 companies below lead on recorded funding and team size among 205 active companies.
Developer of engineered cell therapies for treating various human diseases
OncologyUS$821.00mSeries D · Jun 2020
253-22% 12 mo to Dec 2023LinkedIn · Oct 2026
Physical commerce / Fee-for-service
8 yr2018
0none in 3 months · last posted Jan 2026
Has made acquisitions
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Physical commerce, Fee-for-service
- Team size
- 328 (previous snapshot 570)
- Recorded funding
- US$821.00m · Series D · Jun 2020
- Founded
- 2018 · about 8 years old
- Stage
- Public
- Focus
- Applied genomics, Clinical genomics, Therapeutics, Drugs
Founders · 4
Steve HarrCo-Founder & CEO
Michael MeeCo-Founder
- Highest education
- Biomedical Engineering · Boston University
Jacob RubensCo-Founder
- Highest education
- Healthcare · Mit Sloan School Of Management
Geoffrey MaltzahnCo-Founder
- Highest education
- Doctor of Engineering · MIT
Investors · 11
Baillie GiffordFund
CPP InvestmentsFund- F-Prime CapitalFund
Team & hiring signals
LinkedIn headcount253201-500
LinkedIn followers52,875
Earlier recorded team3282023, a different source
Open roles2of 8 tracked · last posted Jan 2026
Patents
Patent filings361
Focus: Engineered cell therapies and gene delivery platforms for regenerative medicine.
CPC A61K40/11, C12N15/86, C12N5/0676Technology
AWS
PHP
MySQL
Cloudflare
WordPress
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Provider of healthcare data platform for learning services
Life sciences techUS$515.00mSeries C · Jan 2025
475+16% 12 mo to Dec 2023LinkedIn · Oct 2026
Subscription
6 yr2020
3postings · last posted Sep 2026
SaaSSocial impactSoftware
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 250 (previous snapshot 264)
- Recorded funding
- US$515.00m · Series C · Jan 2025
- Founded
- 2020 · about 6 years old
- Stage
- Series C
- Focus
- Provider, Administrative solutions, Data management, Clinical data management
Funding over time
US$515.00m across 3 disclosed equity rounds
Darker bars = larger roundsFounders · 2
Jay NanduriCo-Founder & CTO
- Highest education
- Master's of business administration in management · The Wharton School
Terry MyersonCo-Founder & CEO
- Highest education
- Mechanical Engineering · Duke University
Investors · 9
CommonSpiritFund
IlluminaFund
NorthwellFund
Trinity HealthFund- Advocate HealthFund
Team & hiring signals
LinkedIn headcount475201-500
LinkedIn followers105,153
Earlier recorded team2502023, a different source
Open roles7of 46 tracked · last posted Sep 2026
Patents
Patent filings17
Focus: Privacy-preserving health data integration, normalization, and analytics using de‑identification and ontology matching
CPC G16H10/60, G06F21/6254, G06F16/116Technology
- Azure
- PHP
- MySQL
- Cloudflare
HubSpot
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Developer of proteomics platform for drug development
Life sciences platforms and toolsUS$453.26mSeries C · Feb 2021
150+19% 12 mo to Dec 2022LinkedIn · Oct 2026
Subscription
10 yr2016
0none in 3 months · last posted Oct 2025
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 134 (previous snapshot 120)
- Recorded funding
- US$453.26m · Series C · Feb 2021
- Founded
- 2016 · about 10 years old
- Stage
- Public
- Focus
- Research services, Proteomics
Funding over time
US$453.26m across 3 disclosed equity rounds
Darker bars = larger roundsFounders · 2
Sujal PatelCo-Founder & CEO
- Highest education
- Bachelor's in computer science · University Of Maryland
Parag MallickCo-Founder
- Highest education
- PhD · University of California
Investors · 7
Team & hiring signals
LinkedIn headcount15051-200
LinkedIn followers14,297
Earlier recorded team1342022, a different source
Open roles0of 4 tracked · last posted Oct 2025
Patents
Patent filings90
Focus: Multiplexed single‑molecule protein analysis using nano‑ and micro‑array platforms
CPC G01N33/54353, G16B40/10, C07K1/047Technology
- PHP
- MySQL
- Cloudflare
- HubSpot
- WordPress
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Provider of clinical diagnostics, and drug discovery for immune diseases
Infectious diseasesUS$419.15mSeries F · Jan 2018
643+111% 12 mo to Dec 2022LinkedIn · Oct 2026
Subscription
17 yr2009
0none in 3 months · last posted Feb 2026
Has made acquisitions
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 609
- Recorded funding
- US$419.15m · Series F · Jan 2018
- Founded
- 2009 · about 17 years old
- Stage
- Public
- Focus
- Drugs, Viral, Diversified
Funding over time
US$419.15m across 8 disclosed equity rounds
Darker bars = larger roundsFounders · 2
Harlan Robinsco-founder and chief Scientific Officer
- Highest education
- Bachelor's, Physics · Harvard University
Chad RobinsPresident, CEO & Co-Founder
- Highest education
- Master's of business administration in marketing · The Wharton School
Investors · 12
AlexandriaFund
BD BiosciencesFund
Casdin CapitalFund
CelgeneFund- IlluminaFund
LabCorpFund
MatrixFund
Team & hiring signals
LinkedIn headcount643501-1,000
LinkedIn followers34,871
Earlier recorded team6092022, a different source
Open roles4of 9 tracked · last posted Feb 2026
Recent company signals
- Partnership Partnership with OpenFold Consortium
- Partnership Partnership with BLOODPAC
- Partnership Partnership with Scientist.com
Patents
Patent filings351
Focus: Immune repertoire sequencing for diagnostics, vaccine response, and engineered T‑cell therapies
CPC C12Q1/6881, C12Q1/6886, C12Q1/6869Technology
- PHP
- MySQL
Nginx- WordPress
jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Developer of therapies for the treatment of Idiopathic Pulmonary Fibrosis
Life sciences platforms and toolsUS$388.86mSeries D · Jul 2025
65-31% vs previous recordLinkedIn · Oct 2026
E-commerce - product / Physical commerce
15 yr2011
0none in 3 months · last posted Nov 2025
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Physical commerce
- Team size
- 24 (previous snapshot 35)
- Recorded funding
- US$388.86m · Series D · Jul 2025
- Founded
- 2011 · about 15 years old
- Stage
- Public
- Focus
- Research services, Diversified, Drugs, Fibrosis
Funding over time
US$388.86m across 5 disclosed equity rounds
Darker bars = larger roundsFounders · 2
Richard G. VincentCo-Founder & CFO
Mark SurberFounder
Investors · 20
- CitadelFund
- F-Prime CapitalFund
- Novo HoldingsFund
Team & hiring signals
LinkedIn headcount6511-50
LinkedIn followers9,923
Open roles1of 2 tracked · last posted Nov 2025
Recent company signals
- Milestone target enrollment ahead of schedule target enrollment in Phase 2b MIST trial of inhaled pirfenidone (AP01) in progressive pulmonary fibrosis
Technology
- AWS
- PHP
- MySQL
- Nginx
- WordPress
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Developer of cancer therapeutics
OncologyUS$363.00mSeries C · Jan 2025
237-11% vs previous recordLinkedIn · Jul 2026
Subscription
7 yr2019
0none in 3 months · last posted Jun 2026
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 168 (previous snapshot 189)
- Recorded funding
- US$363.00m · Series C · Jan 2025
- Founded
- 2019 · about 7 years old
- Stage
- Series C
- Focus
- Drugs, Diversified
Funding over time
US$363.00m across 3 disclosed equity rounds
Darker bars = larger roundsFounders · 3
Michael JensenCo-Founder
Andrew ScharenbergCo-Founder & CEO
- Highest education
- The University of North Carolina
Ryan CrismanCo-Founder
- Highest education
- PhD · University of Colorado Boulder
Investors · 18
- AlexandriaFund
- Casdin CapitalFund
DCVCFund
Team & hiring signals
LinkedIn headcount23751-200
LinkedIn followers23,592
Open roles5of 26 tracked · last posted Jun 2026
Recent company signals
- Leadership Hired a Board of Directors
- Award Company of the Year — Colorado BioScience Association
- Partnership Partnership with Nona Biosciences
- Milestone first in vivo CAR T cell therapy to achieve this milestone FDA Fast Track designation for CD19 in vivo CAR T cell therapy UB-VV111
Patents
Patent filings132
Focus: Lentiviral vector manufacturing and engineered stem cell therapies for immuno‑oncology
CPC C12N15/86, C12N5/0646, A61K40/31Technology
- PHP
- MySQL
- Nginx
- WordPress
- jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Developer of cell and gene therapy by using the epigenomic platform
GenomicsUS$222.41mSeries B · Mar 2023
62-15% vs previous recordLinkedIn · Oct 2026
Subscription
17 yr2009
0none in 3 months
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 89 (previous snapshot 105)
- Recorded funding
- US$222.41m · Series B · Mar 2023
- Founded
- 2009 · about 17 years old
- Stage
- Series B
- Focus
- Applied genomics, Clinical genomics, Therapeutics
Funding over time
US$222.41m across 2 disclosed equity rounds
Darker bars = larger roundsFounders · 2
Akira MatsunoCo-Founder, President & CFO
Daniel McHughCo-Founder
- Highest education
- Master's of Science · Stanford University
Investors · 7
- HevolutionFund
- YosemiteFund
Team & hiring signals
LinkedIn headcount6251-200
LinkedIn followers24,246
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Stealth mode immuno-oncology biotech startup
ImmunotherapyUS$211.00mSeries C · Sep 2020
17-53% 12 mo to Dec 2022recorded Dec 2022
Subscription
10 yr2016
0none in 3 months
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 17 (previous snapshot 90)
- Recorded funding
- US$211.00m · Series C · Sep 2020
- Founded
- 2016 · about 10 years old
- Stage
- Public
- Focus
- Drugs, Diversified
Funding over time
US$211.00m across 4 disclosed equity rounds
Darker bars = larger roundsFounders · 1
Peter ThompsonCo-Founder
Investors · 15
- AlexandriaFund
- Boxer CapitalFund
- CelgeneFund
Colt VenturesFund
EcoR1Fund
Patents
Patent filings143
Focus: Develops small‑molecule kinase inhibitors and antibody‑drug conjugates for oncology targets.
CPC C07D401/12, A61K47/6803, C07D401/14Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Developer of vaccines for the treatment of various diseases
Infectious diseasesUS$196.00mSeries B · Mar 2025
44+14% 12 mo to Dec 2021LinkedIn · Jul 2026
Commission on transaction / E-commerce - product
9 yr2017
0none in 3 months
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Commission on transaction, E-commerce - product, Physical commerce
- Team size
- 8 (previous snapshot 31)
- Recorded funding
- US$196.00m · Series B · Mar 2025
- Founded
- 2017 · about 9 years old
- Stage
- Series B
- Focus
- Drugs, Viral, Diversified
Funding over time
US$196.00m across 3 disclosed equity rounds
Darker bars = larger roundsLeadership · 1
George SimeonCEO
Investors · 10
Adjuvant CapitalFund
E&InvestmentFund
Green CrossFund
MedicxiFund
OrbimedFund
Team & hiring signals
LinkedIn headcount4411-50
LinkedIn followers3,520
Earlier recorded team82021, a different source
Patents
Patent filings3
Focus: Herpes zoster immunogenic vaccine formulations and combination vaccine technologies.
CPC A61K39/12, A61P31/22Technology
- PHP
- MySQL
- Nginx
- WordPress
Bootstrap
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Developer of multi-payload antibody-drug conjugates for cancer treatment
OncologyUS$187.00mSeries A · Mar 2025
19LinkedIn · Jul 2026
Physical commerce
2 yr2024
0none in 3 months · last posted Feb 2026
Software
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Physical commerce
- Team size
- Not available
- Recorded funding
- US$187.00m · Series A · Mar 2025
- Founded
- 2024 · about 2 years old
- Stage
- Series A
- Focus
- Autoimmune diseases, Diversified, Drugs
Founders · 2
Jerome KirkupCo-Founder & Chief Scientific Officer
Piers IngramCo-Founder & CEO
Investors · 10
EDBIFund
JeitoFund- Novo HoldingsFund
Omega FundsFund
PlatanusFund
SEEDS CapitalFund
Team & hiring signals
LinkedIn headcount1911-50
LinkedIn followers4,138
Open roles1of 2 tracked · last posted Feb 2026
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Developer of T-cell therapies for cancer treatment
OncologyUS$174.00mSeries B · Jul 2024
73+85% 12 mo to Dec 2022LinkedIn · Jul 2026
Subscription
6 yr2020
0none in 3 months · last posted Oct 2025
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 48 (previous snapshot 55)
- Recorded funding
- US$174.00m · Series B · Jul 2024
- Founded
- 2020 · about 6 years old
- Stage
- Series B
- Focus
- Drugs, Diversified
Funding over time
US$174.00m across 2 disclosed equity rounds
Darker bars = larger roundsFounders · 1
Scott BoykenCo-Founder, Chief Technology Officer
- Highest education
- Doctorates in biology · Iowa State University
Investors · 16
- AlexandriaFund
Artis VenturesFund
- CitadelFund
Team & hiring signals
LinkedIn headcount7351-200
LinkedIn followers7,168
Earlier recorded team482022, a different source
Open roles0of 1 tracked · last posted Oct 2025
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Developer of engineered cell-based therapeutics to restore vision
OphthalmologyUS$155.00mSeries B · Jan 2026
4LinkedIn · Jul 2026
Fee-for-service
6 yr2020
0none in 3 months · last posted Nov 2024
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Fee-for-service
- Team size
- 14
- Recorded funding
- US$155.00m · Series B · Jan 2026
- Founded
- 2020 · about 6 years old
- Stage
- Series B
- Focus
- Drugs, Diversified, Cro
Funding over time
US$155.00m across 2 disclosed equity rounds
Darker bars = larger roundsFounders · 7
Jose SahelCo-Founder
Lyndon CruzCo-Founder
Thomas RehCo-Founder
Vanessa KingCo-Founder
- Highest education
- Doctor of Philosophy, Genetics · University of Cambridge
Pete CoffeyCo-Founder
Olivier GoureauCo-Founder
Deniz DalkaraCo-Founder
Investors · 10
EQTFund- F-Prime CapitalFund
HillhouseFund
QimingFund
Team & hiring signals
LinkedIn headcount451-200
LinkedIn followers2,508
Open roles0of 1 tracked · last posted Nov 2024
Technology
- PHP
- MySQL
- Nginx
- WordPress
- jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Developer of immunotherapies for the treatment of cancer
OncologyUS$149.62mSeries D · Apr 2025
10+44% 12 mo to Dec 2021LinkedIn · Jul 2026
Subscription
11 yr2015
0none in 3 months
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 33
- Recorded funding
- US$149.62m · Series D · Apr 2025
- Founded
- 2015 · about 11 years old
- Stage
- Series D
- Focus
- Drugs, Diversified, Immuno oncology
Funding over time
US$149.62m across 8 disclosed equity rounds
Darker bars = larger roundsFounders · 1
Clifford StocksFounder & CEO
- Highest education
- MBA, Leadership · The University of Chicago Booth School of Business
Investors · 18
- AlexandriaFund
BaxaltaFund
Bering CapitalFund
CanaanFund
Helvetic TrustFund
MD AndersonFund
Team & hiring signals
LinkedIn headcount102-10
LinkedIn followers1,323
Earlier recorded team332021, a different source
Patents
Patent filings56
Focus: LILRB2 immune‑checkpoint antibodies for cancer immunotherapy
CPC C07K16/2896, C07K16/2803, A61K39/3955Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Developer of RNA-targeted therapies intended to treat multiple diseases
Rare diseasesUS$147.50mSeries B · Jul 2021
31+14% 12 mo to Dec 2022LinkedIn · Oct 2026
Subscription
8 yr2018
0none in 3 months
Software
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 117 (previous snapshot 159)
- Recorded funding
- US$147.50m · Series B · Jul 2021
- Founded
- 2018 · about 8 years old
- Stage
- Series B
- Focus
- Drugs, Neurodegenerative, Diversified, Applied genomics
Funding over time
US$147.50m across 2 disclosed equity rounds
Darker bars = larger roundsFounders · 2
Prashant MaliCo-Founder
Francois VigneaultCo-Founder & CEO
- Highest education
- Master's of science in biology · Université Laval
Investors · 6
Decheng CapitalFund
Willett AdvisorsFund
Breton Capital VenturesFund
Team & hiring signals
LinkedIn headcount3151-200
LinkedIn followers13,381
Earlier recorded team1172022, a different source
Recent company signals
- Partnership Partnership with VectorY Therapeutics
Patents
Patent filings175
Focus: Engineering AAV vectors and guide RNAs for enhanced gene‑therapy delivery and expression.
CPC C12N15/113, C12N15/86, C07K14/005Technology
- PHP
- MySQL
- Cloudflare
- WordPress
- jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Biotechnology company improving cancer patient lives through Tumor Paint technology
OncologyUS$123.70mSeries D · Feb 2024
12+29% 12 mo to Dec 2022LinkedIn · Jul 2026
Subscription
16 yr2010
0none in 3 months
Social impactSoftwareHas made acquisitions
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 27 (previous snapshot 34)
- Recorded funding
- US$123.70m · Series D · Feb 2024
- Founded
- 2010 · about 16 years old
- Stage
- Series D
- Focus
- Drugs, Diversified
Funding over time
US$123.70m across 12 disclosed equity rounds
Darker bars = larger roundsLeadership · 1
Heather FranklinPresident and CEO
Team & hiring signals
LinkedIn headcount1211-50
LinkedIn followers1,856
Earlier recorded team272022, a different source
Patents
Patent filings157
Focus: Patents concentrated in chemistry & materials
CPC C07K14/43522, C07K14/47, A61B1/043Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Developer of blood collection device for diagnostic applications
HematologyUS$123.22mSeries B · Dec 2021
101-15% vs previous recordLinkedIn · Jul 2026
E-commerce - product / Physical commerce
12 yr2014
0none in 3 months · last posted Nov 2025
Hardware
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Physical commerce
- Team size
- 104 (previous snapshot 122)
- Recorded funding
- US$123.22m · Series B · Dec 2021
- Founded
- 2014 · about 12 years old
- Stage
- Series B
- Focus
- In vitro diagnostics tests, Blood collection device
Funding over time
US$123.22m across 4 disclosed equity rounds
Darker bars = larger roundsFounders · 1
Erwin BerthierCTO and Co-Founder
Investors · 13
Foresite CapitalFund
InCubeFund- J2 VenturesFund
SVBFund
Team & hiring signals
LinkedIn headcount10151-200
LinkedIn followers10,433
Open roles1of 1 tracked · last posted Nov 2025
Recent company signals
- Award EY Entrepreneur of the Year Award
Patents
Patent filings106
Focus: Microfluidic devices for automated collection and handling of bodily fluids
CPC A61B10/0045, A61B5/15117, A61B5/15115Technology
Angular
TypeScript- Cloudflare
Salesforce- jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Developer of drugs for neurodegenerative diseases
NeurologyUS$121.04mSeries B · Jun 2020
56+82% 12 mo to Dec 2022LinkedIn · Oct 2026
Physical commerce
15 yr2011
0none in 3 months
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Physical commerce
- Team size
- 62 (previous snapshot 50)
- Recorded funding
- US$121.04m · Series B · Jun 2020
- Founded
- 2011 · about 15 years old
- Stage
- Public
- Focus
- Drugs, Neurodegenerative, Diversified
Funding over time
US$121.04m across 7 disclosed equity rounds
Darker bars = larger roundsLeadership · 1
Mark LittonPresident and CEO
Investors · 18
+10 more
Team & hiring signals
LinkedIn headcount5651-200
LinkedIn followers7,660
Earlier recorded team622022, a different source
Recent company signals
- Leadership Hired a Board of Directors
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Developer of diagnostics and therapeutics for amyloid diseases
NeurologyUS$120.45mSeries B · Jun 2023
33-79% vs previous recordLinkedIn · Jul 2026
Subscription
12 yr2014
0none in 3 months · last posted Oct 2025
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 5 (previous snapshot 24)
- Recorded funding
- US$120.45m · Series B · Jun 2023
- Founded
- 2014 · about 12 years old
- Stage
- Series B
- Focus
- Drugs, Neurodegenerative, Diversified
Funding over time
US$120.45m across 3 disclosed equity rounds
Darker bars = larger roundsFounders · 1
Valerie DaggettFounder & CEO
Investors · 6
- AlexandriaFund
Section 32Fund
Senator Investment GroupFund- Eli LillyAngel
Team & hiring signals
LinkedIn headcount3311-50
LinkedIn followers2,136
Earlier recorded team52021, a different source
Open roles0of 1 tracked · last posted Oct 2025
Technology
- PHP
- MySQL
- Nginx
- WordPress
- jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Manufacturer of cytokine based drugs
OncologyUS$119.91mSeries B · Apr 2026
25+86% vs previous recordLinkedIn · Jul 2026
Physical commerce / Subscription
5 yr2021
0none in 3 months
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Physical commerce, Subscription
- Team size
- 54 (previous snapshot 29)
- Recorded funding
- US$119.91m · Series B · Apr 2026
- Founded
- 2021 · about 5 years old
- Stage
- Series B
- Focus
- Drugs, Diversified, Immuno oncology
Funding over time
US$119.91m across 2 disclosed equity rounds
Darker bars = larger roundsFounders · 1
John MulliganFounder & CEO
Investors · 6
3x5 PartnersFund
Codon CapitalFund
RocheFund
Vivo CapitalFund
Team & hiring signals
LinkedIn headcount2511-50
LinkedIn followers5,910
Earlier recorded team542022, a different source
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Developer of an intranasal drug delivery technology for CNS diseases
NeurologyUS$119.88mSeries D · Dec 2018
41+23% 12 mo to Dec 2022LinkedIn · Oct 2026
E-commerce - product / Physical commerce
18 yr2008
0none in 3 months
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Physical commerce
- Team size
- 158
- Recorded funding
- US$119.88m · Series D · Dec 2018
- Founded
- 2008 · about 18 years old
- Stage
- Public
- Focus
- Medical devices, Therapeutic devices, Drug delivery, Inhaled
Funding over time
US$119.88m across 10 disclosed equity rounds
Darker bars = larger roundsFounders · 1
John HoekmanCo-Founder & CSO
- Highest education
- Doctor of Philosophy · University of Washington
Investors · 6
5AM VenturesFund
KKRFund
VenBioFund- Vivo CapitalFund
Team & hiring signals
LinkedIn headcount4151-200
LinkedIn followers9,891
Earlier recorded team1582022, a different source
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Biopharmaceutical company pursuing the development of elemental reducing agents
Cardiac and vascular disordersUS$115.50mSeries B · Nov 2022
4+16% 12 mo to Dec 2022LinkedIn · Jul 2026
Physical commerce
12 yr2014
0none in 3 months
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Physical commerce
- Team size
- 22 (previous snapshot 23)
- Recorded funding
- US$115.50m · Series B · Nov 2022
- Founded
- 2014 · about 12 years old
- Stage
- Series B
- Focus
- Diversified, Drugs
Funding over time
US$115.50m across 4 disclosed equity rounds
Darker bars = larger roundsLeadership · 1
Stephen HillCEO
- Highest education
- Medicine · University Of Oxford
Investors · 5
- AlexandriaFund
Polaris PartnersFund
Team & hiring signals
LinkedIn headcount411-50
LinkedIn followers2,392
Earlier recorded team222022, a different source
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Developer of technologies for the analysis of rare and single cells in the blood
GenomicsUS$114.33mSeries C · Jun 2024
64+8% 12 mo to Dec 2022LinkedIn · Oct 2026
Subscription
17 yr2009
0none in 3 months · last posted Mar 2026
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 54
- Recorded funding
- US$114.33m · Series C · Jun 2024
- Founded
- 2009 · about 17 years old
- Stage
- Series C
- Focus
- Enabling technologies, Kits and reagents, Detection and quantification, Research reagents and kits
Funding over time
US$114.33m across 6 disclosed equity rounds
Darker bars = larger roundsLeadership · 1
Joseph VictorPresident & CEO
Investors · 9
- 5AM VenturesFund
AgilentFund
- F-Prime CapitalFund
LogosFund
- Bill BurkothAngel
Team & hiring signals
LinkedIn headcount6451-200
LinkedIn followers6,444
Earlier recorded team542022, a different source
Open roles1of 1 tracked · last posted Mar 2026
Patents
Patent filings266
Focus: Multiplexed fluorescence microscopy with spectral crosstalk reduction and angle-tuned illumination.
CPC B01L3/50215, B01L3/5021, G02B21/26Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Integrated system to reduce blood culture sample contamination
Life sciences platforms and toolsUS$102.86mSeries C · Jul 2022
81+48% 12 mo to Dec 2021LinkedIn · Jul 2026
Subscription
20 yr2006
0none in 3 months
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 77
- Recorded funding
- US$102.86m · Series C · Jul 2022
- Founded
- 2006 · about 20 years old
- Stage
- Series C
- Focus
- Instruments, Contaminent detection
Funding over time
US$102.86m across 7 disclosed equity rounds
Darker bars = larger roundsFounders · 2
Gregory BullingtonCo-Founder & CEO
- Highest education
- Business Administration · University Of Washington - Michael G. Foster School Of Business
Richard PattonCo-Founder & Medical Director
Investors · 7
RTW InvestmentsFund
SectoralFund
Canepa HealthcareFund
Team & hiring signals
LinkedIn headcount8151-200
LinkedIn followers4,810
Earlier recorded team772021, a different source
Patents
Patent filings433
Focus: Medical fluid handling devices for sampling, control, and contamination‑free delivery
CPC A61B5/150221, A61B5/150251, A61B10/0045Technology
- PHP
- MySQL
- Cloudflare
- Salesforce
Zendesk
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Developer of RNA-sequencing solution-based transcriptome kit to analyze health data
Life sciences platforms and toolsUS$100.26mSeries C · Dec 2023
135-3% vs previous recordLinkedIn · Jul 2026
Subscription
8 yr2018
0none in 3 months · last posted Jul 2026
Has made acquisitions
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 107 (previous snapshot 110)
- Recorded funding
- US$100.26m · Series C · Dec 2023
- Founded
- 2018 · about 8 years old
- Stage
- Series C
- Focus
- Enabling technologies, Kits and reagents, Detection and quantification, Research reagents and kits
Funding over time
US$100.26m across 5 disclosed equity rounds
Darker bars = larger roundsFounders · 2
Geoff KrummelCo-Founder
Alex RosenbergCo-Founder & CEO
- Highest education
- BA · Washington University in St. Louis
Investors · 7
- LogosFund
Marshall WaceFund
Sahsen VenturesFund
Soleus CapitalFund- Saras CapitalFund
Team & hiring signals
LinkedIn headcount13551-200
LinkedIn followers26,097
Open roles4of 11 tracked · last posted Jul 2026
Technology
- AWS
- PHP
- MySQL
- Cloudflare
Sentry
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Developer of drugs for neurodegenerative disease based on genetic screening, and multi-omics approach
GenomicsUS$96.00mSeries A · Nov 2022
60+22% vs previous recordrecorded
Subscription
6 yr2020
—No postings tracked
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 60 (previous snapshot 49)
- Recorded funding
- US$96.00m · Series A · Nov 2022
- Founded
- 2020 · about 6 years old
- Stage
- Series A
- Focus
- Applied genomics, Clinical genomics, Therapeutics, Drugs
Founders · 2
Ian PeikonCo-Founder
Andrew DervanCo-Founder
Investors · 7
- AlexandriaFund
- EvotecFund
Lux CapitalFund
The Column GroupFund
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Developer of enzyme design technology to bridge the gap by creating synthetic enzymes
Life sciences platforms and toolsUS$95.21mSeries B · Aug 2025
79+36% 12 mo to Dec 2022LinkedIn · Oct 2026
Physical commerce
18 yr2008
0none in 3 months
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Physical commerce
- Team size
- 60
- Recorded funding
- US$95.21m · Series B · Aug 2025
- Founded
- 2008 · about 18 years old
- Stage
- Series B
- Focus
- Research services, Proteomics
Funding over time
US$94.96m across 7 disclosed equity rounds
Darker bars = larger roundsFounders · 3
David BakerCo-Founder
Daniela Grabs-RothlisbergerCo-Founder
- Highest education
- PhD · University of Zurich
Alexandre ZanghelliniCo-Founder & CEO
- Highest education
- PhD · University of Washington
Investors · 17
BungeFund- Casdin CapitalFund
OS FundFund
Team & hiring signals
LinkedIn headcount7951-200
LinkedIn followers9,395
Earlier recorded team602022, a different source
Recent company signals
- Leadership Hired a Chief Operating Officer
- Partnership Partnership with KENT Specialty Milling
- Partnership Partnership with MANE
Patents
Patent filings85
Focus: Enzymatic synthesis and modification of steviol glycoside sweeteners
CPC C12P19/56, C12N9/1051, C12N9/90Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Developer of DNA sequencing technology to identify genomic mutations
GenomicsUS$84.02mSeries B · Jun 2023
13-22% 12 mo to Dec 2022LinkedIn · Jul 2026
Subscription
11 yr2015
0none in 3 months
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 70 (previous snapshot 110)
- Recorded funding
- US$84.02m · Series B · Jun 2023
- Founded
- 2015 · about 11 years old
- Stage
- Series B
- Focus
- Genome informatics, Sequence analysis
Funding over time
US$84.02m across 5 disclosed equity rounds
Darker bars = larger roundsFounders · 2
Mike SchmittCo-Founder
- Highest education
- Doctor of Philosophy, Biochemistry · University of Washington
Jesse SalkCo-Founder
- Highest education
- Doctor of medicine in molecular biology · University Of Washington - School Of Medicine
Investors · 7
- AlexandriaFund
S32Fund- Sahsen VenturesFund
- Soleus CapitalFund
Team & hiring signals
LinkedIn headcount1351-200
LinkedIn followers5,810
Earlier recorded team702022, a different source
Technology
- PHP
- MySQL
- Nginx
- Cloudflare
- HubSpot
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Developer of therapeutics for treating inflammatory and autoimmune diseases
ImmunologyUS$80.00mSeries A · Jun 2023
36+40% 12 mo to Dec 2021LinkedIn · Jul 2026
Fee-for-service
6 yr2020
0none in 3 months
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Fee-for-service
- Team size
- 14 (previous snapshot 37)
- Recorded funding
- US$80.00m · Series A · Jun 2023
- Founded
- 2020 · about 6 years old
- Stage
- Series A
- Focus
- Drugs, Diversified
Funding over time
US$80.00m across 2 disclosed equity rounds
Darker bars = larger roundsLeadership · 1
Katie FanningCEO
- Highest education
- Miami University
Investors · 12
AbbVieFund- AlexandriaFund
BayerFund
Leaps by BayerFund
LillyFund
PfizerFund
Team & hiring signals
LinkedIn headcount3611-50
LinkedIn followers3,521
Earlier recorded team142021, a different source
Technology
- Cloudflare
- jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Developer of visualization system for surgeries
Surgical instrumentsUS$74.25mSeries B · Jul 2023
3,032+53% 12 mo to Dec 2021LinkedIn · Oct 2026
Subscription
10 yr2016
0none in 3 months · last posted Oct 2025
Hardware
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 52 (previous snapshot 315)
- Recorded funding
- US$74.25m · Series B · Jul 2023
- Founded
- 2016 · about 10 years old
- Stage
- Series B
- Focus
- Navigation systems
Funding over time
US$74.25m across 4 disclosed equity rounds
Darker bars = larger roundsLeadership · 1
Gabriel JonesCEO
Investors · 5
BIRD BFund
- Cota CapitalFund
- DCVCFund
- Alan FrazierAngel
Team & hiring signals
LinkedIn headcount3,03251-200
LinkedIn followers13,648
Earlier recorded team522021, a different source
Open roles0of 12 tracked · last posted Oct 2025
Recent company signals
- Milestone 4th FDA clearance for Paradigm AI platform FDA clearance for Paradigm platform
Patents
Patent filings125
Focus: Patents concentrated in health & consumer products
CPC A61B34/20, G06T17/00, A61B90/37Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Developer of biological drugs for the treatment of infectious diseases
Infectious diseasesUS$73.00mSeries C · Sep 2023
104-27% vs previous recordLinkedIn · Oct 2026
Physical commerce
15 yr2011
0none in 3 months
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Physical commerce
- Team size
- 67 (previous snapshot 92)
- Recorded funding
- US$73.00m · Series C · Sep 2023
- Founded
- 2011 · about 15 years old
- Stage
- Series C
- Focus
- Drugs, Diversified
Funding over time
US$73.00m across 5 disclosed equity rounds
Darker bars = larger roundsFounders · 1
Brian FinrowCEO & Founder
Investors · 4
WestRiver GroupFund
Avista DevelopmentFund
Team & hiring signals
LinkedIn headcount10451-200
LinkedIn followers8,308
Recent company signals
- Leadership Hired a clinical development team member
- Leadership Hired a Executive Vice President (EVP)
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Discovering human monoclonal antibodies for safe and effective therapeutic product development
ImmunotherapyUS$61.16mSeries B · May 2015
19-5% 12 mo to Dec 2022recorded Dec 2022
Subscription
22 yr2004
0none in 3 months
Software
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 19
- Recorded funding
- US$61.16m · Series B · May 2015
- Founded
- 2004 · about 22 years old
- Stage
- Series B
- Focus
- Drugs, Diversified, Viral
Funding over time
US$61.16m across 7 disclosed equity rounds
Darker bars = larger roundsLeadership · 1
Clifford J StocksCEO
- Highest education
- MBA, Leadership · The University of Chicago Booth School of Business
Investors · 8
- AlexandriaFund
- CanaanFund
Versant VenturesFund- MPM CapitalFund
- Zenyaku KogyoFund
Patents
Patent filings225
Focus: Broadly neutralizing monoclonal antibodies targeting HIV-1 envelope glycoprotein (gp120/gp41)
CPC C07K16/114, C07K16/108, C07K16/1145Technology
- PHP
- jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Developer of therapeutic solutions for vision care
OphthalmologyUS$56.00mSeries A · Aug 2021
134+289% 12 mo to Dec 2021LinkedIn · Jul 2026
E-commerce - product / Physical commerce
7 yr2019
0none in 3 months · last posted Mar 2026
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Physical commerce
- Team size
- 35 (previous snapshot 43)
- Recorded funding
- US$56.00m · Series A · Aug 2021
- Founded
- 2019 · about 7 years old
- Stage
- Series A
- Focus
- Drugs, Retinal disorders
Funding over time
US$56.00m across 2 disclosed equity rounds
Darker bars = larger roundsInvestors · 5
- RTW InvestmentsFund
Wille FinanceFund- Sage GroupFund
Team & hiring signals
LinkedIn headcount13451-200
LinkedIn followers12,093
Earlier recorded team352021, a different source
Open roles1of 1 tracked · last posted Mar 2026
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Provider of direct-to-consumer genetic testing.
Healthcare booking platformsUS$53.60mSeries C · Jun 2017
160recorded
Subscription
12 yr2014
0none in 3 months
Consumer
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 160
- Recorded funding
- US$53.60m · Series C · Jun 2017
- Founded
- 2014 · about 12 years old
- Stage
- Series C
- Focus
- Applied genomics, Consumer genomics, Health and wellness, Diagnostics
Funding over time
US$49.60m across 2 disclosed equity rounds
Darker bars = larger roundsFounders · 3
Clayton LewisCo-Founder & CEO
- Highest education
- BA, Business Administration · University of Washington
Nathan PriceCo-Founder
- Highest education
- Doctorates in bioengineering · Uc San Diego
Leroy HoodCo-Founder
- Highest education
- MD · Johns Hopkins Medicine
Investors · 3
MaveronFund- Polaris PartnersFund
Patents
Patent filings2
Focus: Predictive health analytics linking dynamic biomarkers to disease risk
CPC G16B40/00, G16B40/10Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Developer of cell-based tool for the measurements of protein interactions
Life sciences platforms and toolsUS$45.24mSeries A · Jul 2023
49-9% vs previous recordLinkedIn · Jul 2026
Subscription
9 yr2017
0none in 3 months
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 39 (previous snapshot 43)
- Recorded funding
- US$45.24m · Series A · Jul 2023
- Founded
- 2017 · about 9 years old
- Stage
- Series A
- Focus
- Research services, Proteomics
Funding over time
US$45.24m across 3 disclosed equity rounds
Darker bars = larger roundsFounders · 1
Randolph LopezCo-founder & CTO
- Highest education
- Bioengineering · University Of Washington
Investors · 9
BOOMFund
- Lux CapitalFund
- OS FundFund
- Sahsen VenturesFund
Team & hiring signals
LinkedIn headcount4911-50
LinkedIn followers12,603
Earlier recorded team392022, a different source
Recent company signals
- Award 2026 Alumni Entrepreneurs of the year — University of Washington's Buerk Center for Entrepreneurship
- Launch Launched Synthetic Epitope Atlas (SEP) (antibodies-antigen structural data generation)
Technology
React
Netlify
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Developer of programmed B cell therapies for protein delivery
Rare diseasesUS$44.13mSeries B · May 2024
22-17% vs previous recordLinkedIn · Jul 2026
Subscription
17 yr2009
0none in 3 months
Social impactSoftwareHas made acquisitions
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 20 (previous snapshot 24)
- Recorded funding
- US$44.13m · Series B · May 2024
- Founded
- 2009 · about 17 years old
- Stage
- Series B
- Focus
- Drugs, Metabolic disorders
Funding over time
US$44.13m across 7 disclosed equity rounds
Darker bars = larger roundsFounders · 1
Matthew ScholzFounder
- Highest education
- Bachelor's of Science · University of Washington
Investors · 13
- AlexandriaFund
DEFTA PartnersFund
Founders FundFund
Ikarian CapitalFund
RBV CapitalFund
Team & hiring signals
LinkedIn headcount2211-50
LinkedIn followers3,630
Patents
Patent filings66
Focus: Engineered B cells as living factories for therapeutic protein delivery and disease modulation
CPC C12N5/0635, C12N15/867, A61K38/465Technology
- PHP
- MySQL
- WordPress
- jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Developer of therapeutic devices for corneal transplant
OphthalmologyUS$42.00mSeries B · Feb 2019
180+2% 12 mo to Dec 2020LinkedIn · Jul 2026
E-commerce - product / Physical commerce
9 yr2017
0none in 3 months · last posted Oct 2025
HardwareHas made acquisitions
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Physical commerce
- Team size
- 205
- Recorded funding
- US$42.00m · Series B · Feb 2019
- Founded
- 2017 · about 9 years old
- Stage
- Series B
- Focus
- Medical devices, Therapy, Corneal disorders
Funding over time
US$42.00m across 2 disclosed equity rounds
Darker bars = larger roundsLeadership · 1
Monty MontoyaCEO & President
- Highest education
- Master's of business administration · Duke University - The Fuqua School Of Business
Investors · 2
PetrichorFund
Team & hiring signals
LinkedIn headcount18051-200
LinkedIn followers3,827
Earlier recorded team2052020, a different source
Open roles0of 2 tracked · last posted Oct 2025
Recent company signals
- Milestone 2,000 completed CTAK surgeries
- Milestone 2000 and 2001 completed CTAK treatment completion
Technology
- AWS
- PHP
- MySQL
- Cloudflare
- Salesforce
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Developing innovative drugs and devices to preserve and restore vision
OphthalmologyUS$38.84mSeries C · Sep 2009
25-8% 12 mo to Dec 2016LinkedIn · Oct 2026
E-commerce - product / Physical commerce
24 yr2002
0none in 3 months
ConsumerSocial impactSoftwareHardware
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Physical commerce
- Team size
- 45
- Recorded funding
- US$38.84m · Series C · Sep 2009
- Founded
- 2002 · about 24 years old
- Stage
- Public
- Focus
- Drugs, Diversified
Funding over time
US$38.84m across 3 disclosed equity rounds
Darker bars = larger roundsLeadership · 1
Ryo KubotaChairman, president & CEO
- Highest education
- Harvard Business School Executive Education
Investors · 3
Team & hiring signals
LinkedIn headcount2511-50
LinkedIn followers2,293
Earlier recorded team452016, a different source
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Developer of therapeutic solutions for treating severe liver diseases
ImmunologyUS$35.00mSeries A · Nov 2020
6LinkedIn · Jul 2026
Physical commerce
8 yr2018
0none in 3 months
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Physical commerce
- Team size
- Not available
- Recorded funding
- US$35.00m · Series A · Nov 2020
- Founded
- 2018 · about 8 years old
- Stage
- Series A
- Focus
- Drugs, Liver diseases, Inflammatory diseases
Founders · 1
Brian FarmerCo-Founder & CEO
- Highest education
- Master's of Business Administration · McCombs School of Business
Investors · 4
- 5AM VenturesFund
Jubilant BiosysFund
Wu CapitalFund
Team & hiring signals
LinkedIn headcount6
LinkedIn followers11
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Developer of ultrasound device to non-invasively detect middle ear infections
Ent disordersUS$34.79mSeries C · Oct 2022
22+7% vs previous recordLinkedIn · Jul 2026
Subscription
16 yr2010
0none in 3 months
Hardware
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 16 (previous snapshot 15)
- Recorded funding
- US$34.79m · Series C · Oct 2022
- Founded
- 2010 · about 16 years old
- Stage
- Series C
- Focus
- Medical devices, Screening devices, Ear
Funding over time
US$34.79m across 7 disclosed equity rounds
Darker bars = larger roundsFounders · 1
Caitlin CameronCo-Founder & CEO
Investors · 3
Keiretsu CapitalFund
Keiretsu ForumFund
Team & hiring signals
LinkedIn headcount2211-50
LinkedIn followers1,523
Recent company signals
- Award Washington's Best Workplaces for 2025 — Washington
- Leadership Hired a VP of Strategic Business Operations
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Developing RNA therapeutics for orphan liver cancer and inherited metabolic diseases.
Rare diseasesUS$32.82mSeries A · Dec 2015
3LinkedIn · Oct 2026
E-commerce - product / Physical commerce
20 yr2006
0none in 3 months
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Physical commerce
- Team size
- 21
- Recorded funding
- US$32.82m · Series A · Dec 2015
- Founded
- 2006 · about 20 years old
- Stage
- Public
- Focus
- Drugs, Diversified
Funding over time
US$32.82m across 8 disclosed equity rounds
Darker bars = larger roundsFounders · 1
Paul JohnsonFounder, Director (BOD), Advisor
- Highest education
- Biology · Caltech
Investors · 3
- 5AM VenturesFund
- Versant VenturesFund
Team & hiring signals
LinkedIn headcount311-50
LinkedIn followers70
Earlier recorded team212016, a different source
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Translational oncology company pioneering drug development with its CIVO platform
Life sciences platforms and toolsUS$32.39mSeries E · Mar 2021
10-19% 12 mo to Dec 2022LinkedIn · Jul 2026
E-commerce - product / Physical commerce
18 yr2008
0none in 3 months
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Physical commerce
- Team size
- 17 (previous snapshot 15)
- Recorded funding
- US$32.39m · Series E · Mar 2021
- Founded
- 2008 · about 18 years old
- Stage
- Series E
- Focus
- Research assays, Drug discovery, Immunoassays
Funding over time
US$32.39m across 5 disclosed equity rounds
Darker bars = larger roundsFounders · 1
Jim OlsonFounder and Chairman
- Highest education
- Marketing · University of Derby
Investors · 5
- CelgeneFund
- LabCorpFund
TakedaFund
Takeda VenturesFund
Team & hiring signals
LinkedIn headcount1011-50
LinkedIn followers2,124
Earlier recorded team172022, a different source
Patents
Patent filings90
Focus: Oncology combination drugs and low-profile multi-agent injection delivery systems
CPC A61K31/4025, A61M5/3298, A61K31/40Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Developer of computational drug discovery platform
Life sciences techUS$32.00mSeries A · Jul 2022
29LinkedIn · Jul 2026
Subscription
5 yr2021
0none in 3 months
Artificial IntelligenceSoftware
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 12
- Recorded funding
- US$32.00m · Series A · Jul 2022
- Founded
- 2021 · about 5 years old
- Stage
- Series A
- Focus
- Research & development, Drug discovery, Cheminformatics, Lead discovery
Funding over time
US$32.00m across 2 disclosed equity rounds
Darker bars = larger roundsFounders · 2
Raphael GottardoCo-Founder
- Highest education
- PhD, Statistics · University of Washington
Greg FinakCo-Founder
- Highest education
- Doctorates in biochemistry · Mcgill University
Investors · 8
- AlexandriaFund
- Duke UniversityFund
- M12Fund
OCV PartnersFund- VulcanFund
Team & hiring signals
LinkedIn headcount2911-50
LinkedIn followers2,851
Earlier recorded team122021, a different source
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Developer of cloud-based protein-modelling software for drug discovery
Life sciences techUS$31.99mSeries B · Feb 2024
17+28% 12 mo to Dec 2022LinkedIn · Jul 2026
Subscription
12 yr2014
0none in 3 months
SaaSSoftwareHas made acquisitions
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 23
- Recorded funding
- US$31.99m · Series B · Feb 2024
- Founded
- 2014 · about 12 years old
- Stage
- Series B
- Focus
- Research & development, Drug discovery, Proteomics
Funding over time
US$31.99m across 7 disclosed equity rounds
Darker bars = larger roundsFounders · 3
Lucas NivonCo-Founder & CEO
Yifan SongCo-Founder & CSO
- Highest education
- Doctorates in physics · Ccny School Of Education
Javier CastellanoCo-Founder & CTO
Investors · 10
Agent CapitalFund
Alumni VenturesFund
Medtech WingsFund- OrbimedFund
The W FundFund
Trinity VenturesFund
Team & hiring signals
LinkedIn headcount1711-50
LinkedIn followers4,724
Earlier recorded team232022, a different source
Technology
- PHP
- MySQL
- WordPress
- jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Immuno-oncology company developing novel therapies to empower the immune system
ImmunotherapyUS$31.09mSeries B · Oct 2022
6LinkedIn · Jul 2026
Fee-for-service
17 yr2009
0none in 3 months
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Fee-for-service
- Team size
- 9
- Recorded funding
- US$31.09m · Series B · Oct 2022
- Founded
- 2009 · about 17 years old
- Stage
- Series B
- Focus
- Drugs, Diversified
Funding over time
US$31.09m across 5 disclosed equity rounds
Darker bars = larger roundsLeadership · 1
Mark BurnsPresident & CEO
- Highest education
- Chemistry · Rice University
Team & hiring signals
LinkedIn headcount62-10
LinkedIn followers776
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Manufacturer of synthetic biomaterials and implantable medical devices
Life sciences platforms and toolsUS$28.54mSeries C · Dec 2025
9+25% vs previous recordLinkedIn · Jul 2026
Fee-for-service
19 yr2007
0none in 3 months
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Fee-for-service
- Team size
- 10 (previous snapshot 8)
- Recorded funding
- US$28.54m · Series C · Dec 2025
- Founded
- 2007 · about 19 years old
- Stage
- Series C
- Focus
- Research services, Diversified
Funding over time
US$28.54m across 9 disclosed equity rounds
Darker bars = larger roundsLeadership · 1
Mike ConnollyCEO & Chairman
- Highest education
- Master's of business administration in business administration · Stanford University
Investors · 9
- Keiretsu CapitalFund
- Keiretsu ForumFund
ZINO SocietyFund
Bellingham Angel GroupFund- Carl LombardiAngel
Team & hiring signals
LinkedIn headcount92-10
LinkedIn followers724
Patents
Patent filings42
Focus: Improving vascular graft patency and injectable porous ocular drug‑delivery devices.
CPC A61F2/91, A61L27/56, A61L27/58Technology
- PHP
- MySQL
- Nginx
- WordPress
- jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Developer of a therapeutic device for the treatment of cancer
OncologyUS$28.43mSeries B · Nov 2018
13+0% 12 mo to Dec 2010LinkedIn · Jul 2026
E-commerce - product / Physical commerce
24 yr2002
0none in 3 months
Hardware
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Physical commerce
- Team size
- 13
- Recorded funding
- US$28.43m · Series B · Nov 2018
- Founded
- 2002 · about 24 years old
- Stage
- Series B
- Focus
- Medical devices, Therapies, Chemotherapy, Electrochemo therapy
Funding over time
US$28.43m across 9 disclosed equity rounds
Darker bars = larger roundsFounders · 1
Lisa Buttersex-Co-Founder
Team & hiring signals
LinkedIn headcount1311-50
LinkedIn followers896
Earlier recorded team132010, a different source
Patents
Patent filings81
Focus: Wireless electromagnetic coil systems for targeted cancer therapy, especially glioblastoma treatment.
CPC G01N37/005, A61N2/02, G01R33/032Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Developer of genetically targeted intervention therapy for age-related diseases
Cell therapyUS$27.51mSeries A · Jun 2024
17-18% vs previous recordLinkedIn · Jul 2026
Subscription
12 yr2014
0none in 3 months
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 18 (previous snapshot 22)
- Recorded funding
- US$27.51m · Series A · Jun 2024
- Founded
- 2014 · about 12 years old
- Stage
- Series A
- Focus
- Drugs, Metabolic disorders, Gene therapy
Funding over time
US$27.51m across 3 disclosed equity rounds
Darker bars = larger roundsFounders · 2
Gary HudsonCo-Founder & Chairman
Matthew ScholzCo-Founder & CEO
- Highest education
- Bachelor's of Science · University of Washington
Investors · 6
- AbbVieFund
Althea GroupFund
Forever HealthyFund
KizooFund
- Michael GreveAngel
Team & hiring signals
LinkedIn headcount1711-50
LinkedIn followers2,812
Technology
- jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Provider of precision medicine platform based on patient-derived organoids
OncologyUS$27.35mSeries A · Mar 2023
26-43% vs previous recordrecorded
Fee-for-service
11 yr2015
—No postings tracked
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Fee-for-service
- Team size
- 26 (previous snapshot 46)
- Recorded funding
- US$27.35m · Series A · Mar 2023
- Founded
- 2015 · about 11 years old
- Stage
- Series A
- Focus
- In-vitro diagnostic tests, Pan cancer
Funding over time
US$27.35m across 5 disclosed equity rounds
Darker bars = larger roundsFounders · 5
Carla GrandoriCo-Founder & CEO
- Highest education
- PhD · Rockefeller University
Eduardo MendezCo-Founder
- Highest education
- University of Washington
V K GADICo-Founder
Christopher KempCo-Founder
- Highest education
- Genetics · Beatson Institute For Cancer Research
Brady BernardCo-Founder
Investors · 2
AletheaFund
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Manufacturer of drugs for multiple therapautic areas
Life sciences techUS$26.00mSeries B · Dec 2025
57-4% vs previous recordLinkedIn · Jul 2026
Subscription
11 yr2015
0none in 3 months
SaaSSoftwareHas made acquisitions
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 47 (previous snapshot 49)
- Recorded funding
- US$26.00m · Series B · Dec 2025
- Founded
- 2015 · about 11 years old
- Stage
- Series B
- Focus
- Ai based, Cheminformatics, Drug discovery, Lead discovery
Funding over time
US$26.00m across 3 disclosed equity rounds
Darker bars = larger roundsLeadership · 1
Nicholas GeisseCEO
- Highest education
- PhD · University of Cambridge
Investors · 5
DSFund
Dynamk CapitalFund
UTC InvestmentFund- Dream CISFund
Team & hiring signals
LinkedIn headcount5711-50
LinkedIn followers9,734
Earlier recorded team472022, a different source
Technology
- AWS
- Angular
- TypeScript
- Cloudflare
- HubSpot
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Specialty company developing novel treatment for hearing loss
Ent disordersUS$25.19mSeries B · Jun 2018
1-83% 12 mo to Sep 2013recorded Sep 2013
Physical commerce / Subscription
24 yr2002
0none in 3 months
ConsumerSoftware
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Physical commerce, Subscription
- Team size
- 1
- Recorded funding
- US$25.19m · Series B · Jun 2018
- Founded
- 2002 · about 24 years old
- Stage
- Series B
- Focus
- Drugs
Funding over time
US$25.19m across 6 disclosed equity rounds
Darker bars = larger roundsLeadership · 1
Jonathan KilCEO & CMO
- Highest education
- University Of Washington - School Of Medicine
Technology
- Java
- PHP
- MySQL
- Nginx
- Cloudflare
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
No matching company in this list.
50 of 205 companies shown here · the full list is on Radar
Fliar Radar
Explore all 205 life sciences companies in Seattle on Radar
This page shows the top 50. Radar has the complete, filterable list with contacts and live company signals.
Open life sciences in Seattle on Radar- Every company, not just 50All 205 life sciences companies in Seattle, filterable by stage, funding, team size, revenue model and age.
- Founders and decision-makersLeadership teams with roles and verified LinkedIn profiles, ready for outreach.
- Live signalsFunding rounds, hiring, launches and M&A as they happen, with alerts on the companies you follow.
- Save and exportBuild lists, compare companies side by side and export them from your Radar account.
Explore life sciences companies in Seattle by what you are looking for
Browse life sciences companies in Seattle across research platforms, oncology and genomics. Find life science companies developing diagnostics, therapies and tools.
9 ways to explore life sciences in Seattle
Life sciences platforms and tools companiesOncology companiesGenomics companiesImmunotherapy and immunology companiesNeurology companiesInfectious disease companies
Life sciences platforms and tools companies
Research platforms, laboratory tools and scientific technology providers.
- Nautilus BiotechnologySee in list
Developer of proteomics platform for drug development
Life sciences platforms and tools - Avalyn PharmaSee in list
Developer of therapies for the treatment of Idiopathic Pulmonary Fibrosis
Life sciences platforms and tools - Magnolia MedicalSee in list
Integrated system to reduce blood culture sample contamination
Life sciences platforms and tools - ArzedaSee in list
Developer of enzyme design technology to bridge the gap by creating synthetic enzymes
Life sciences platforms and tools - A-Alpha BioSee in list
Developer of cell-based tool for the measurements of protein interactions
Life sciences platforms and tools
72 companies in SeattleAll 52 life sciences platforms and tools companies in Seattle →
Oncology companies
Cancer therapy and oncology biotechnology companies.
- Sana BiotechnologySee in list
Developer of engineered cell therapies for treating various human diseases
Oncology - Umoja BiopharmaSee in list
Developer of cancer therapeutics
Oncology - Silverback TherapeuticsSee in list
Stealth mode immuno-oncology biotech startup
Immunotherapy - Callio TherapeuticsSee in list
Developer of multi-payload antibody-drug conjugates for cancer treatment
Oncology - Outpace BioSee in list
Developer of T-cell therapies for cancer treatment
Oncology
64 companies in SeattleAll 47 oncology companies in Seattle →
Genomics companies
Genomics, sequencing and clinical genetics companies.
- Sana BiotechnologySee in list
Developer of engineered cell therapies for treating various human diseases
Oncology - Tune TherapeuticsSee in list
Developer of cell and gene therapy by using the epigenomic platform
Genomics - Shape TherapeuticsSee in list
Developer of RNA-targeted therapies intended to treat multiple diseases
Rare diseases - RareCyteSee in list
Developer of technologies for the analysis of rare and single cells in the blood
Genomics - Parse BiosciencesSee in list
Developer of RNA-sequencing solution-based transcriptome kit to analyze health data
Life sciences platforms and tools
37 companies in SeattleAll 38 genomics companies in Seattle →
Immunotherapy and immunology companies
Immune-system therapies and immunology research companies.
- Sana BiotechnologySee in list
Developer of engineered cell therapies for treating various human diseases
Oncology - Umoja BiopharmaSee in list
Developer of cancer therapeutics
Oncology - Callio TherapeuticsSee in list
Developer of multi-payload antibody-drug conjugates for cancer treatment
Oncology - InipharmSee in list
Developer of therapeutic solutions for treating severe liver diseases
Immunology - Aminex TherapeuticsSee in list
Immuno-oncology company developing novel therapies to empower the immune system
Immunotherapy
35 companies in SeattleAll 1,069 immunotherapy companies in United States →
Neurology companies
Neurology and neurodegenerative disease treatment developers.
- Shape TherapeuticsSee in list
Developer of RNA-targeted therapies intended to treat multiple diseases
Rare diseases - Athira PharmaSee in list
Developer of drugs for neurodegenerative diseases
Neurology - AltPepSee in list
Developer of diagnostics and therapeutics for amyloid diseases
Neurology - Cajal NeuroscienceSee in list
Developer of drugs for neurodegenerative disease based on genetic screening, and multi-omics approach
Genomics 
PhysioSonicsUltrasound imaging to monitor blood flow in the brain
Neurology
22 companies in SeattleAll 1,624 neurology companies in United States →
Infectious disease companies
Infectious disease diagnostics, vaccines and treatment developers.
- Adaptive BiotechnologiesSee in list
Provider of clinical diagnostics, and drug discovery for immune diseases
Infectious diseases - CurevoSee in list
Developer of vaccines for the treatment of various diseases
Infectious diseases - LumenSee in list
Developer of biological drugs for the treatment of infectious diseases
Infectious diseases - Theraclone SciencesSee in list
Discovering human monoclonal antibodies for safe and effective therapeutic product development
Immunotherapy 
Anavasi DiagnosticsManufacturer of molecular detector for COVID-19
Infectious diseases
29 companies in SeattleAll 1,010 infectious diseases companies in United States →
Public life sciences companies in Seattle
Publicly listed life sciences companies operating in Seattle.
- Sana BiotechnologySee in list
Developer of engineered cell therapies for treating various human diseases
Oncology - Nautilus BiotechnologySee in list
Developer of proteomics platform for drug development
Life sciences platforms and tools - Adaptive BiotechnologiesSee in list
Provider of clinical diagnostics, and drug discovery for immune diseases
Infectious diseases - Avalyn PharmaSee in list
Developer of therapies for the treatment of Idiopathic Pulmonary Fibrosis
Life sciences platforms and tools - Silverback TherapeuticsSee in list
Stealth mode immuno-oncology biotech startup
Immunotherapy
16 companies in Seattle
Life sciences startups in Seattle
Recently founded life sciences companies in Seattle.
- Callio TherapeuticsSee in list
Developer of multi-payload antibody-drug conjugates for cancer treatment
Oncology - Bonum TherapeuticsSee in list
Manufacturer of cytokine based drugs
Oncology - OzetteSee in list
Developer of computational drug discovery platform
Life sciences tech 
MonodDeveloper of biosensors to detect viral proteins, toxins, antibodies, and other molecules
Life sciences platforms and tools
Archon BioProvider of computational platform to develop protein therapeutics
Life sciences tech
30 companies in Seattle
Life sciences companies hiring in Seattle
Life sciences companies in Seattle with hiring activity.
- Sana BiotechnologySee in list
Developer of engineered cell therapies for treating various human diseases
Oncology - TruvetaSee in list
Provider of healthcare data platform for learning services
Life sciences tech - Nautilus BiotechnologySee in list
Developer of proteomics platform for drug development
Life sciences platforms and tools - Adaptive BiotechnologiesSee in list
Provider of clinical diagnostics, and drug discovery for immune diseases
Infectious diseases - Avalyn PharmaSee in list
Developer of therapies for the treatment of Idiopathic Pulmonary Fibrosis
Life sciences platforms and tools
19 companies in Seattle
For investors and data teams
Put this intelligence into your own tools
The figures on this page come from Fliar’s company, funding, hiring and news data. Use it through the Investor Intelligence API and company data exports, or explore every company, founder and investor in Radar.
Capital & corporate activity
Life sciences funding and M&A across the United States
22,455 recorded equity rounds have gone to 27,407 life sciences companies in the United States — how much, at which stage, into which sub-sectors, from whom, and how Seattle compares. Debt, IPO and grant rounds are excluded.
equity rounds, last 12 months360
US$13.54bn
equity rounds, last 24 months1232
US$37.38bn
raised over five yearsUS$157.58bn
5,603 rounds in the United States
M&A deals, Seattle30
last 24 months
Capital by year
amount roundsEquity funding into life sciences in the United States
Bars show US$ raised; the number under each year is equity rounds. 2026 is year to date. The peak year was 2021, with US$45.29bn across 1383 rounds.
The funding ladder · five years
Rounds and typical cheque by stage
AngelUS$70.78m18 rounds · median US$1.40m
SeedUS$5.87bn1,808 rounds · median US$1.11m
Series AUS$38.68bn1,753 rounds · median US$8.80m
Series BUS$46.06bn1,089 rounds · median US$23.00m
Series CUS$30.98bn517 rounds · median US$42.00m
Series D+US$35.59bn392 rounds · median US$50.00m
Private equityUS$66.54m22 rounds · median US$14.25m
Where the money went · five years
Most-funded sub-sectors
OncologyUS$24.87bn658 rounds · 368 companies
Life sciences techUS$16.70bn556 rounds · 344 companies
GenomicsUS$15.90bn409 rounds · 249 companies
NeurologyUS$13.39bn445 rounds · 248 companies
ImmunologyUS$12.90bn189 rounds · 111 companies
Life sciences platforms and toolsUS$7.97bn387 rounds · 238 companies
Cardiac and vascular disordersUS$7.63bn313 rounds · 172 companies
Seattle in context
Seattle’s share of the United States’s life sciences funding
Equity rounds over the last five years, 305 life sciences companies in Seattle among 27,407 in the United States.
Corporate activity · last 24 months
M&A in Seattle
25Acquisition
5Merger
Most active acquirers
- Varian medical systems5
- At&t3
- Qiagen2
- Tuhura biosciences2
- Tend health1
Most acquired or merged
- Lumen6
- Parse biosciences3
- Curevo Vaccine2
- Kineta2
- Varian medical systems2
Each deal appears in the events strip at the top of the page.
Go deeper in the life sciences landscape reports:
Life Sciences Industry Landscape of Seattle Life Sciences Industry Landscape of the United States AdTech Industry Landscape of SeattleIndustry landscape report
Life Sciences Industry Landscape of Seattle
The financials above are one chapter. The full life sciences landscape of Seattle maps the whole industry — every segment, the capital behind it, the talent market and where the next opportunities are.
- Market map of every sub-sector
- Funding & company formation by year
- Revenue, profit & financial strength
- Digital footprint: traffic, apps, releases
- Hiring, skills & pay
- Founders & leaders
- News & sentiment
- Where demand runs ahead of supply
Life sciences funding in Seattle
101 life sciences companies in Seattle have recorded equity funding, US$7.11bn in total. Totals and round dates describe the historical record; they are not current valuations.
Most funded
Largest recorded equity totals, with the latest recorded round.
OncologyDeveloper of engineered cell therapies for treating various human diseases
Recorded equity fundingUS$821.00mSeries D · Jun 2020
Founders · 4
Steve HarrCo-Founder & CEO
Michael MeeCo-Founder
Jacob RubensCo-Founder
Geoffrey MaltzahnCo-Founder
Life sciences techProvider of healthcare data platform for learning services
Recorded equity fundingUS$515.00mSeries C · Jan 2025
Founders · 2
Jay NanduriCo-Founder & CTO
Terry MyersonCo-Founder & CEO
Life sciences platforms and toolsDeveloper of proteomics platform for drug development
Recorded equity fundingUS$453.26mSeries C · Feb 2021
Founders · 2
Sujal PatelCo-Founder & CEO
Parag MallickCo-Founder
Infectious diseasesProvider of clinical diagnostics, and drug discovery for immune diseases
Recorded equity fundingUS$419.15mSeries F · Jan 2018
Founders · 2
Harlan Robinsco-founder and chief Scientific Officer
Chad RobinsPresident, CEO & Co-Founder
Life sciences platforms and toolsDeveloper of therapies for the treatment of Idiopathic Pulmonary Fibrosis
Recorded equity fundingUS$388.86mSeries D · Jul 2025
Founders · 2
Richard G. VincentCo-Founder & CFO
Mark SurberFounder
OncologyDeveloper of cancer therapeutics
Recorded equity fundingUS$363.00mSeries C · Jan 2025
Founders · 3
Michael JensenCo-Founder
Andrew ScharenbergCo-Founder & CEO
Ryan CrismanCo-Founder
GenomicsDeveloper of cell and gene therapy by using the epigenomic platform
Recorded equity fundingUS$222.41mSeries B · Mar 2023
Founders · 2
Akira MatsunoCo-Founder, President & CFO
Daniel McHughCo-Founder
ImmunotherapyStealth mode immuno-oncology biotech startup
Recorded equity fundingUS$211.00mSeries C · Sep 2020
Founder · 1
Peter ThompsonCo-Founder
Infectious diseasesDeveloper of vaccines for the treatment of various diseases
Recorded equity fundingUS$196.00mSeries B · Mar 2025
Leadership · 1
George SimeonCEO
OncologyDeveloper of multi-payload antibody-drug conjugates for cancer treatment
Recorded equity fundingUS$187.00mSeries A · Mar 2025
Founders · 2
Jerome KirkupCo-Founder & Chief Scientific Officer
Piers IngramCo-Founder & CEO
OncologyDeveloper of T-cell therapies for cancer treatment
Recorded equity fundingUS$174.00mSeries B · Jul 2024
Founder · 1
Scott BoykenCo-Founder, Chief Technology Officer
OphthalmologyDeveloper of engineered cell-based therapeutics to restore vision
Recorded equity fundingUS$155.00mSeries B · Jan 2026
Founders · 7
Jose SahelCo-Founder
Lyndon CruzCo-Founder
Thomas RehCo-Founder
Vanessa KingCo-Founder
Pete CoffeyCo-Founder
Olivier GoureauCo-Founder
Deniz DalkaraCo-Founder
OncologyDeveloper of immunotherapies for the treatment of cancer
Recorded equity fundingUS$149.62mSeries D · Apr 2025
Founder · 1
Clifford StocksFounder & CEO
Rare diseasesDeveloper of RNA-targeted therapies intended to treat multiple diseases
Recorded equity fundingUS$147.50mSeries B · Jul 2021
Founders · 2
Prashant MaliCo-Founder
Francois VigneaultCo-Founder & CEO
OncologyBiotechnology company improving cancer patient lives through Tumor Paint technology
Recorded equity fundingUS$123.70mSeries D · Feb 2024
Leadership · 1
Heather FranklinPresident and CEO
HematologyDeveloper of blood collection device for diagnostic applications
Recorded equity fundingUS$123.22mSeries B · Dec 2021
Founder · 1
Erwin BerthierCTO and Co-Founder
Has made acquisitions
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Physical commerce, Fee-for-service
- Team size
- 328 (previous snapshot 570)
- Recorded funding
- US$821.00m · Series D · Jun 2020
- Founded
- 2018 · about 8 years old
- Stage
- Public
- Focus
- Applied genomics, Clinical genomics, Therapeutics, Drugs
Founders · 4
Steve HarrCo-Founder & CEO
Michael MeeCo-Founder
- Highest education
- Biomedical Engineering · Boston University
Jacob RubensCo-Founder
- Highest education
- Healthcare · Mit Sloan School Of Management
Geoffrey MaltzahnCo-Founder
- Highest education
- Doctor of Engineering · MIT
Investors · 11
- Baillie GiffordFund
- CPP InvestmentsFund
- F-Prime CapitalFund
Team & hiring signals
LinkedIn headcount253201-500
LinkedIn followers52,875
Earlier recorded team3282023, a different source
Open roles2of 8 tracked · last posted Jan 2026
Patents
Patent filings361
Focus: Engineered cell therapies and gene delivery platforms for regenerative medicine.
CPC A61K40/11, C12N15/86, C12N5/0676Technology
- AWS
- PHP
- MySQL
- Cloudflare
- WordPress
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
SaaSSocial impactSoftware
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 250 (previous snapshot 264)
- Recorded funding
- US$515.00m · Series C · Jan 2025
- Founded
- 2020 · about 6 years old
- Stage
- Series C
- Focus
- Provider, Administrative solutions, Data management, Clinical data management
Funding over time
US$515.00m across 3 disclosed equity rounds
Darker bars = larger roundsFounders · 2
Jay NanduriCo-Founder & CTO
- Highest education
- Master's of business administration in management · The Wharton School
Terry MyersonCo-Founder & CEO
- Highest education
- Mechanical Engineering · Duke University
Investors · 9
- CommonSpiritFund
- IlluminaFund
- NorthwellFund
- Trinity HealthFund
- Advocate HealthFund
Team & hiring signals
LinkedIn headcount475201-500
LinkedIn followers105,153
Earlier recorded team2502023, a different source
Open roles7of 46 tracked · last posted Sep 2026
Patents
Patent filings17
Focus: Privacy-preserving health data integration, normalization, and analytics using de‑identification and ontology matching
CPC G16H10/60, G06F21/6254, G06F16/116Technology
- Azure
- PHP
- MySQL
- Cloudflare
- HubSpot
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 134 (previous snapshot 120)
- Recorded funding
- US$453.26m · Series C · Feb 2021
- Founded
- 2016 · about 10 years old
- Stage
- Public
- Focus
- Research services, Proteomics
Funding over time
US$453.26m across 3 disclosed equity rounds
Darker bars = larger roundsFounders · 2
Sujal PatelCo-Founder & CEO
- Highest education
- Bachelor's in computer science · University Of Maryland
Parag MallickCo-Founder
- Highest education
- PhD · University of California
Investors · 7
Team & hiring signals
LinkedIn headcount15051-200
LinkedIn followers14,297
Earlier recorded team1342022, a different source
Open roles0of 4 tracked · last posted Oct 2025
Patents
Patent filings90
Focus: Multiplexed single‑molecule protein analysis using nano‑ and micro‑array platforms
CPC G01N33/54353, G16B40/10, C07K1/047Technology
- PHP
- MySQL
- Cloudflare
- HubSpot
- WordPress
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Has made acquisitions
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 609
- Recorded funding
- US$419.15m · Series F · Jan 2018
- Founded
- 2009 · about 17 years old
- Stage
- Public
- Focus
- Drugs, Viral, Diversified
Funding over time
US$419.15m across 8 disclosed equity rounds
Darker bars = larger roundsFounders · 2
Harlan Robinsco-founder and chief Scientific Officer
- Highest education
- Bachelor's, Physics · Harvard University
Chad RobinsPresident, CEO & Co-Founder
- Highest education
- Master's of business administration in marketing · The Wharton School
Investors · 12
- AlexandriaFund
- BD BiosciencesFund
- Casdin CapitalFund
- CelgeneFund
- IlluminaFund
- LabCorpFund
- MatrixFund
Team & hiring signals
LinkedIn headcount643501-1,000
LinkedIn followers34,871
Earlier recorded team6092022, a different source
Open roles4of 9 tracked · last posted Feb 2026
Recent company signals
- Partnership Partnership with OpenFold Consortium
- Partnership Partnership with BLOODPAC
- Partnership Partnership with Scientist.com
Patents
Patent filings351
Focus: Immune repertoire sequencing for diagnostics, vaccine response, and engineered T‑cell therapies
CPC C12Q1/6881, C12Q1/6886, C12Q1/6869Technology
- PHP
- MySQL
- Nginx
- WordPress
- jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Physical commerce
- Team size
- 24 (previous snapshot 35)
- Recorded funding
- US$388.86m · Series D · Jul 2025
- Founded
- 2011 · about 15 years old
- Stage
- Public
- Focus
- Research services, Diversified, Drugs, Fibrosis
Funding over time
US$388.86m across 5 disclosed equity rounds
Darker bars = larger roundsFounders · 2
Richard G. VincentCo-Founder & CFO
Mark SurberFounder
Investors · 20
- CitadelFund
- F-Prime CapitalFund
- Novo HoldingsFund
Team & hiring signals
LinkedIn headcount6511-50
LinkedIn followers9,923
Open roles1of 2 tracked · last posted Nov 2025
Recent company signals
- Milestone target enrollment ahead of schedule target enrollment in Phase 2b MIST trial of inhaled pirfenidone (AP01) in progressive pulmonary fibrosis
Technology
- AWS
- PHP
- MySQL
- Nginx
- WordPress
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 168 (previous snapshot 189)
- Recorded funding
- US$363.00m · Series C · Jan 2025
- Founded
- 2019 · about 7 years old
- Stage
- Series C
- Focus
- Drugs, Diversified
Funding over time
US$363.00m across 3 disclosed equity rounds
Darker bars = larger roundsFounders · 3
Michael JensenCo-Founder
Andrew ScharenbergCo-Founder & CEO
- Highest education
- The University of North Carolina
Ryan CrismanCo-Founder
- Highest education
- PhD · University of Colorado Boulder
Investors · 18
- AlexandriaFund
- Casdin CapitalFund
- DCVCFund
Team & hiring signals
LinkedIn headcount23751-200
LinkedIn followers23,592
Open roles5of 26 tracked · last posted Jun 2026
Recent company signals
- Leadership Hired a Board of Directors
- Award Company of the Year — Colorado BioScience Association
- Partnership Partnership with Nona Biosciences
- Milestone first in vivo CAR T cell therapy to achieve this milestone FDA Fast Track designation for CD19 in vivo CAR T cell therapy UB-VV111
Patents
Patent filings132
Focus: Lentiviral vector manufacturing and engineered stem cell therapies for immuno‑oncology
CPC C12N15/86, C12N5/0646, A61K40/31Technology
- PHP
- MySQL
- Nginx
- WordPress
- jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 89 (previous snapshot 105)
- Recorded funding
- US$222.41m · Series B · Mar 2023
- Founded
- 2009 · about 17 years old
- Stage
- Series B
- Focus
- Applied genomics, Clinical genomics, Therapeutics
Funding over time
US$222.41m across 2 disclosed equity rounds
Darker bars = larger roundsFounders · 2
Akira MatsunoCo-Founder, President & CFO
Daniel McHughCo-Founder
- Highest education
- Master's of Science · Stanford University
Investors · 7
- HevolutionFund
- YosemiteFund
Team & hiring signals
LinkedIn headcount6251-200
LinkedIn followers24,246
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 17 (previous snapshot 90)
- Recorded funding
- US$211.00m · Series C · Sep 2020
- Founded
- 2016 · about 10 years old
- Stage
- Public
- Focus
- Drugs, Diversified
Funding over time
US$211.00m across 4 disclosed equity rounds
Darker bars = larger roundsFounders · 1
Peter ThompsonCo-Founder
Investors · 15
- AlexandriaFund
- Boxer CapitalFund
- CelgeneFund
- Colt VenturesFund
- EcoR1Fund
Patents
Patent filings143
Focus: Develops small‑molecule kinase inhibitors and antibody‑drug conjugates for oncology targets.
CPC C07D401/12, A61K47/6803, C07D401/14Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Commission on transaction, E-commerce - product, Physical commerce
- Team size
- 8 (previous snapshot 31)
- Recorded funding
- US$196.00m · Series B · Mar 2025
- Founded
- 2017 · about 9 years old
- Stage
- Series B
- Focus
- Drugs, Viral, Diversified
Funding over time
US$196.00m across 3 disclosed equity rounds
Darker bars = larger roundsLeadership · 1
George SimeonCEO
Investors · 10
- Adjuvant CapitalFund
- E&InvestmentFund
- Green CrossFund
- MedicxiFund
- OrbimedFund
Team & hiring signals
LinkedIn headcount4411-50
LinkedIn followers3,520
Earlier recorded team82021, a different source
Patents
Patent filings3
Focus: Herpes zoster immunogenic vaccine formulations and combination vaccine technologies.
CPC A61K39/12, A61P31/22Technology
- PHP
- MySQL
- Nginx
- WordPress
- Bootstrap
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Software
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Physical commerce
- Team size
- Not available
- Recorded funding
- US$187.00m · Series A · Mar 2025
- Founded
- 2024 · about 2 years old
- Stage
- Series A
- Focus
- Autoimmune diseases, Diversified, Drugs
Founders · 2
Jerome KirkupCo-Founder & Chief Scientific Officer
Piers IngramCo-Founder & CEO
Investors · 10
- EDBIFund
- JeitoFund
- Novo HoldingsFund
- Omega FundsFund
- PlatanusFund
- SEEDS CapitalFund
Team & hiring signals
LinkedIn headcount1911-50
LinkedIn followers4,138
Open roles1of 2 tracked · last posted Feb 2026
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 48 (previous snapshot 55)
- Recorded funding
- US$174.00m · Series B · Jul 2024
- Founded
- 2020 · about 6 years old
- Stage
- Series B
- Focus
- Drugs, Diversified
Funding over time
US$174.00m across 2 disclosed equity rounds
Darker bars = larger roundsFounders · 1
Scott BoykenCo-Founder, Chief Technology Officer
- Highest education
- Doctorates in biology · Iowa State University
Investors · 16
- AlexandriaFund
- Artis VenturesFund
- CitadelFund
Team & hiring signals
LinkedIn headcount7351-200
LinkedIn followers7,168
Earlier recorded team482022, a different source
Open roles0of 1 tracked · last posted Oct 2025
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Fee-for-service
- Team size
- 14
- Recorded funding
- US$155.00m · Series B · Jan 2026
- Founded
- 2020 · about 6 years old
- Stage
- Series B
- Focus
- Drugs, Diversified, Cro
Funding over time
US$155.00m across 2 disclosed equity rounds
Darker bars = larger roundsFounders · 7
Jose SahelCo-Founder
Lyndon CruzCo-Founder
Thomas RehCo-Founder
Vanessa KingCo-Founder
- Highest education
- Doctor of Philosophy, Genetics · University of Cambridge
Pete CoffeyCo-Founder
Olivier GoureauCo-Founder
Deniz DalkaraCo-Founder
Investors · 10
- EQTFund
- F-Prime CapitalFund
- HillhouseFund
- QimingFund
Team & hiring signals
LinkedIn headcount451-200
LinkedIn followers2,508
Open roles0of 1 tracked · last posted Nov 2024
Technology
- PHP
- MySQL
- Nginx
- WordPress
- jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 33
- Recorded funding
- US$149.62m · Series D · Apr 2025
- Founded
- 2015 · about 11 years old
- Stage
- Series D
- Focus
- Drugs, Diversified, Immuno oncology
Funding over time
US$149.62m across 8 disclosed equity rounds
Darker bars = larger roundsFounders · 1
Clifford StocksFounder & CEO
- Highest education
- MBA, Leadership · The University of Chicago Booth School of Business
Investors · 18
- AlexandriaFund
- BaxaltaFund
- Bering CapitalFund
- CanaanFund
- Helvetic TrustFund
- MD AndersonFund
Team & hiring signals
LinkedIn headcount102-10
LinkedIn followers1,323
Earlier recorded team332021, a different source
Patents
Patent filings56
Focus: LILRB2 immune‑checkpoint antibodies for cancer immunotherapy
CPC C07K16/2896, C07K16/2803, A61K39/3955Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Software
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 117 (previous snapshot 159)
- Recorded funding
- US$147.50m · Series B · Jul 2021
- Founded
- 2018 · about 8 years old
- Stage
- Series B
- Focus
- Drugs, Neurodegenerative, Diversified, Applied genomics
Funding over time
US$147.50m across 2 disclosed equity rounds
Darker bars = larger roundsFounders · 2
Prashant MaliCo-Founder
Francois VigneaultCo-Founder & CEO
- Highest education
- Master's of science in biology · Université Laval
Investors · 6
- Decheng CapitalFund
- Willett AdvisorsFund
- Breton Capital VenturesFund
Team & hiring signals
LinkedIn headcount3151-200
LinkedIn followers13,381
Earlier recorded team1172022, a different source
Recent company signals
- Partnership Partnership with VectorY Therapeutics
Patents
Patent filings175
Focus: Engineering AAV vectors and guide RNAs for enhanced gene‑therapy delivery and expression.
CPC C12N15/113, C12N15/86, C07K14/005Technology
- PHP
- MySQL
- Cloudflare
- WordPress
- jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Social impactSoftwareHas made acquisitions
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 27 (previous snapshot 34)
- Recorded funding
- US$123.70m · Series D · Feb 2024
- Founded
- 2010 · about 16 years old
- Stage
- Series D
- Focus
- Drugs, Diversified
Funding over time
US$123.70m across 12 disclosed equity rounds
Darker bars = larger roundsLeadership · 1
Heather FranklinPresident and CEO
Team & hiring signals
LinkedIn headcount1211-50
LinkedIn followers1,856
Earlier recorded team272022, a different source
Patents
Patent filings157
Focus: Patents concentrated in chemistry & materials
CPC C07K14/43522, C07K14/47, A61B1/043Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Hardware
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Physical commerce
- Team size
- 104 (previous snapshot 122)
- Recorded funding
- US$123.22m · Series B · Dec 2021
- Founded
- 2014 · about 12 years old
- Stage
- Series B
- Focus
- In vitro diagnostics tests, Blood collection device
Funding over time
US$123.22m across 4 disclosed equity rounds
Darker bars = larger roundsFounders · 1
Erwin BerthierCTO and Co-Founder
Investors · 13
- Foresite CapitalFund
- InCubeFund
- J2 VenturesFund
- SVBFund
Team & hiring signals
LinkedIn headcount10151-200
LinkedIn followers10,433
Open roles1of 1 tracked · last posted Nov 2025
Recent company signals
- Award EY Entrepreneur of the Year Award
Patents
Patent filings106
Focus: Microfluidic devices for automated collection and handling of bodily fluids
CPC A61B10/0045, A61B5/15117, A61B5/15115Technology
- Angular
- TypeScript
- Cloudflare
- Salesforce
- jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Founders and momentum in Seattle
Meet the people behind life sciences companies in Seattle. 160 of 205 companies list founders or leaders; where a public LinkedIn profile matches exactly, the expanded profile shows the photo, headline, location and education.
Growing teams
Companies whose recorded headcount rose the most between the two most recent team-size snapshots. A larger team is a signal of momentum, not of profitability.
Life sciences techProvider of AI-based genomic medicine platform
Team size55Up from 12 in the previous snapshot
Founder · 1
Gabriel RichmanFounder & CEO
OncologyManufacturer of cytokine based drugs
Team size54Up from 29 in the previous snapshot
Founder · 1
John MulliganFounder & CEO
OncologyCanCure LLC is an anticancer drug development startup venture with the mission to transform the proprietary innovative cancer immunotherapeutic technology into clinic.
Team size11Up from 6 in the previous snapshot
Founders
Details not available
Life sciences techProvider of software for 3D visualization of images
Team size27Up from 15 in the previous snapshot
Leadership · 2
Nicholas RederCEO
Nicholas RederCEO
Infectious diseasesManufacturer of molecular detector for COVID-19
Team size30Up from 18 in the previous snapshot
Founders · 3
Minh DuongCo-Founder
Robert AtkinsonCo-Founder
Barry LutzCo-Founder & CSO
Nutraceuticals techManufacturer of gummy nutraceutical and pharmaceutical products
Team size19Up from 12 in the previous snapshot
Leadership · 1
Connie WanCEO
OncologyProvider of drug discovery platform for gene regulators
Team size15Up from 10 in the previous snapshot
Founders · 2
Alex FederationCo-Founder & CEO
Lindsay PinoCo-Founder and CTO
Life sciences platforms and toolsManufacturer of synthetic biomaterials and implantable medical devices
Team size10Up from 8 in the previous snapshot
Leadership · 1
Mike ConnollyCEO & Chairman
Life sciences platforms and toolsUW Bioengineering is inventing the future of medicine through cutting-edge biomedical engineering research and education.
Team size123Up from 99 in the previous snapshot
Founders
Details not available
NeurologyDeveloper of drugs for neurodegenerative diseases
Team size62Up from 50 in the previous snapshot
Leadership · 1
Mark LittonPresident and CEO
GenomicsDeveloper of drugs for neurodegenerative disease based on genetic screening, and multi-omics approach
Team size60Up from 49 in the previous snapshot
Founders · 2
Ian PeikonCo-Founder
Andrew DervanCo-Founder
Life sciences platforms and toolsThe mission of the Allen Institute for Cell Science is to create dynamic and multi-scale visual models of cell organization, dynamics and activities that capture experimental observation, theory and prediction to understand and predict cellular behavior in its normal, regenerative, and pathological
Team size79Up from 68 in the previous snapshot
Founders
Details not available
Artificial IntelligenceSoftware
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 55 (previous snapshot 12)
- Recorded funding
- None recorded
- Founded
- 2017 · about 9 years old
- Stage
- Funding Raised
- Focus
- Research & development, Drug informatics, Clinical data analysis, Omics analysis
Founders · 1
Gabriel RichmanFounder & CEO
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Physical commerce, Subscription
- Team size
- 54 (previous snapshot 29)
- Recorded funding
- US$119.91m · Series B · Apr 2026
- Founded
- 2021 · about 5 years old
- Stage
- Series B
- Focus
- Drugs, Diversified, Immuno oncology
Funding over time
US$119.91m across 2 disclosed equity rounds
Darker bars = larger roundsFounders · 1
John MulliganFounder & CEO
Investors · 6
- 3x5 PartnersFund
- Codon CapitalFund
- RocheFund
- Vivo CapitalFund
Team & hiring signals
LinkedIn headcount2511-50
LinkedIn followers5,910
Earlier recorded team542022, a different source
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Physical commerce
- Team size
- 11 (previous snapshot 6)
- Recorded funding
- None recorded
- Founded
- 2013 · about 13 years old
- Stage
- Not available
- Focus
- Autoimmune diseases, Diversified, Drugs
Team & hiring signals
LinkedIn headcount42-10
LinkedIn followers99
Patents
Patent filings10
Focus: Therapeutic antibodies targeting MIC antigens for cancer immunotherapy
CPC C07K16/2833Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
SaaSSoftware
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 27 (previous snapshot 15)
- Recorded funding
- US$7.58m · Series A · Mar 2024
- Founded
- 2014 · about 12 years old
- Stage
- Series A
- Focus
- Research & development, Image analysis, Super resolution microscopy, Pathology
Funding over time
US$7.58m across 2 disclosed equity rounds
Darker bars = larger roundsLeadership · 2
Nicholas RederCEO
- Highest education
- MD, Medicine · LOYOLA UNIVERSITY CHICAGO
Nicholas RederCEO
- Highest education
- MD, Medicine · LOYOLA UNIVERSITY CHICAGO
Investors · 1
- Dynamk CapitalFund
Team & hiring signals
LinkedIn headcount3211-50
LinkedIn followers6,309
Technology
- Angular
- TypeScript
- Cloudflare
- HubSpot
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 30 (previous snapshot 18)
- Recorded funding
- US$6.00m · Angel · Nov 2021
- Founded
- 2020 · about 6 years old
- Stage
- Seed
- Focus
- In vitro diagnostic tests, Viral, Sars-cov-2, Rapid diagnostic tests
Founders · 3
Minh DuongCo-Founder
Robert AtkinsonCo-Founder
- Highest education
- BMath · University of Waterloo
Barry LutzCo-Founder & CSO
- Highest education
- Doctorates in chemical engineering · University Of Washington
Team & hiring signals
LinkedIn headcount911-50
LinkedIn followers1,410
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Consumer
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Physical commerce
- Team size
- 19 (previous snapshot 12)
- Recorded funding
- None recorded
- Founded
- 2016 · about 10 years old
- Stage
- Series A
- Focus
- Dietary supplements, Disease specific, Diversified
Leadership · 1
Connie WanCEO
Team & hiring signals
LinkedIn headcount811-50
LinkedIn followers934
Recent company signals
- Partnership Partnership with Fuller's Marketplace
Technology
- React
- Cloudflare
- Bootstrap
- jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Software
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 15 (previous snapshot 10)
- Recorded funding
- US$19.82m · Seed · Jul 2024
- Founded
- 2020 · about 6 years old
- Stage
- Seed
- Focus
- Research & development, Drug discovery, Proteomics, Research assays
Funding over time
US$19.82m across 4 disclosed equity rounds
Darker bars = larger roundsFounders · 2
Alex FederationCo-Founder & CEO
- Highest education
- Harvard University
Lindsay PinoCo-Founder and CTO
Investors · 7
BoxOne VenturesFund
Fifty YearsFund
FundersClubFund
NFXFund
Two Bear CapitalFund
Y CombinatorFund
Team & hiring signals
LinkedIn headcount2911-50
LinkedIn followers5,684
Open roles2of 2 tracked · last posted Jan 2026
- Hiring: Research Associate II · Seattle
- Internship: Business Development Intern · Seattle
Recent company signals
- Partnership Partnership with Lilly TuneLab
Patents
Patent filings27
Focus: Automotive interior storage and organization systems for floor and cargo compartments
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Fee-for-service
- Team size
- 10 (previous snapshot 8)
- Recorded funding
- US$28.54m · Series C · Dec 2025
- Founded
- 2007 · about 19 years old
- Stage
- Series C
- Focus
- Research services, Diversified
Funding over time
US$28.54m across 9 disclosed equity rounds
Darker bars = larger roundsLeadership · 1
Mike ConnollyCEO & Chairman
- Highest education
- Master's of business administration in business administration · Stanford University
Investors · 9
- Keiretsu CapitalFund
- Keiretsu ForumFund
- ZINO SocietyFund
- Bellingham Angel GroupFund
- Carl LombardiAngel
Team & hiring signals
LinkedIn headcount92-10
LinkedIn followers724
Patents
Patent filings42
Focus: Improving vascular graft patency and injectable porous ocular drug‑delivery devices.
CPC A61F2/91, A61L27/56, A61L27/58Technology
- PHP
- MySQL
- Nginx
- WordPress
- jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Fee-for-service
- Team size
- 123 (previous snapshot 99)
- Recorded funding
- None recorded
- Founded
- Not available
- Stage
- Not available
- Focus
- Diversified, Research services
Team & hiring signals
LinkedIn headcount118201-500
LinkedIn followers2,753
Recent company signals
- Award College of Fellows Class of 2026 — American Institute for Medical and Biological Engineering
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Physical commerce
- Team size
- 62 (previous snapshot 50)
- Recorded funding
- US$121.04m · Series B · Jun 2020
- Founded
- 2011 · about 15 years old
- Stage
- Public
- Focus
- Drugs, Neurodegenerative, Diversified
Funding over time
US$121.04m across 7 disclosed equity rounds
Darker bars = larger roundsLeadership · 1
Mark LittonPresident and CEO
Investors · 18
+10 moreTeam & hiring signals
LinkedIn headcount5651-200
LinkedIn followers7,660
Earlier recorded team622022, a different source
Recent company signals
- Leadership Hired a Board of Directors
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 60 (previous snapshot 49)
- Recorded funding
- US$96.00m · Series A · Nov 2022
- Founded
- 2020 · about 6 years old
- Stage
- Series A
- Focus
- Applied genomics, Clinical genomics, Therapeutics, Drugs
Founders · 2
Ian PeikonCo-Founder
Andrew DervanCo-Founder
Investors · 7
- AlexandriaFund
- EvotecFund
- Lux CapitalFund
- The Column GroupFund
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 79 (previous snapshot 68)
- Recorded funding
- None recorded
- Founded
- Not available
- Stage
- Not available
- Focus
- Diversified, Research services
Team & hiring signals
Open roles5of 17 tracked · last posted May 2026
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Women-founded
Life sciences companies in Seattle with at least one woman on the founding team. Expand a profile to meet the founders; teams can include both women and men.
GenomicsDeveloper of cell and gene therapy by using the epigenomic platform
Revenue modelSubscription
Founders · 2
Akira MatsunoCo-Founder, President & CFO
Daniel McHughCo-Founder
Life sciences platforms and toolsDeveloper of enzyme design technology to bridge the gap by creating synthetic enzymes
Revenue modelPhysical commerce
Founders · 3
David BakerCo-Founder
Daniela Grabs-RothlisbergerCo-Founder
Alexandre ZanghelliniCo-Founder & CEO
OncologyProvider of precision medicine platform based on patient-derived organoids
Revenue modelFee-for-service
Founders · 5
Carla GrandoriCo-Founder & CEO
Eduardo MendezCo-Founder
V K GADICo-Founder
Christopher KempCo-Founder
Brady BernardCo-Founder
Life sciences platforms and toolsSmall molecule and biologics for regenerative medicine, oncology, and fully human biologics
Revenue modelSubscription
Founder · 1
Theresa DeisherFounder & CEO
OphthalmologyDeveloper of engineered cell-based therapeutics to restore vision
Revenue modelFee-for-service
Founders · 7
Jose SahelCo-Founder
Lyndon CruzCo-Founder
Thomas RehCo-Founder
Vanessa KingCo-Founder
Pete CoffeyCo-Founder
Olivier GoureauCo-Founder
Deniz DalkaraCo-Founder
Life sciences platforms and toolsProvider of progenitor blood and immune cells for clinical application
Revenue modelSubscription
Founder · 1
Colleen DelaneyFounder
OncologyDeveloper of a therapeutic device for the treatment of cancer
Revenue modelE-commerce - product / Physical commerce
Founder · 1
Lisa Buttersex-Co-Founder
GenomicsManufacturer of microbiome cap device for medical treatment
Revenue modelFee-for-service
Founders · 2
Thomas LendvayCo-Founder & Chief Medical Officer
Kathleen LendvayCo-founder, President and COO
Women healthProvider of DNA and hormone analysis based birth control optimization kits
Revenue modelSubscription
Founder · 1
Elizabeth RuzzoFounder & CEO
Life sciences techAI-powered key opinion leader management system for medical affairs professionals
Revenue modelAdvertising / Commission on transaction
Founders · 2
Gordon SilvermanCo-Founder
Mahek ChhatrapatiCo-Founder & CEO
Life sciences platforms and toolsOffers biobanking services
Revenue modelPhysical commerce
Founders · 2
Jenna StrullyCo-Founder
Alex JiaoCo-Founder & CEO
Hospital equipmentProvider of infusion rate monitoring devices
Revenue modelSubscription
Founders · 2
Beth KolkoCo-Founder & CEO
Koji IntlekoferCo-Founder & CTO
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 89 (previous snapshot 105)
- Recorded funding
- US$222.41m · Series B · Mar 2023
- Founded
- 2009 · about 17 years old
- Stage
- Series B
- Focus
- Applied genomics, Clinical genomics, Therapeutics
Funding over time
US$222.41m across 2 disclosed equity rounds
Darker bars = larger roundsFounders · 2
Akira MatsunoCo-Founder, President & CFO
Daniel McHughCo-Founder
- Highest education
- Master's of Science · Stanford University
Investors · 7
- HevolutionFund
- YosemiteFund
Team & hiring signals
LinkedIn headcount6251-200
LinkedIn followers24,246
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Physical commerce
- Team size
- 60
- Recorded funding
- US$95.21m · Series B · Aug 2025
- Founded
- 2008 · about 18 years old
- Stage
- Series B
- Focus
- Research services, Proteomics
Funding over time
US$94.96m across 7 disclosed equity rounds
Darker bars = larger roundsFounders · 3
David BakerCo-Founder
Daniela Grabs-RothlisbergerCo-Founder
- Highest education
- PhD · University of Zurich
Alexandre ZanghelliniCo-Founder & CEO
- Highest education
- PhD · University of Washington
Investors · 17
- BungeFund
- Casdin CapitalFund
- OS FundFund
Team & hiring signals
LinkedIn headcount7951-200
LinkedIn followers9,395
Earlier recorded team602022, a different source
Recent company signals
- Leadership Hired a Chief Operating Officer
- Partnership Partnership with KENT Specialty Milling
- Partnership Partnership with MANE
Patents
Patent filings85
Focus: Enzymatic synthesis and modification of steviol glycoside sweeteners
CPC C12P19/56, C12N9/1051, C12N9/90Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Fee-for-service
- Team size
- 26 (previous snapshot 46)
- Recorded funding
- US$27.35m · Series A · Mar 2023
- Founded
- 2015 · about 11 years old
- Stage
- Series A
- Focus
- In-vitro diagnostic tests, Pan cancer
Funding over time
US$27.35m across 5 disclosed equity rounds
Darker bars = larger roundsFounders · 5
Carla GrandoriCo-Founder & CEO
- Highest education
- PhD · Rockefeller University
Eduardo MendezCo-Founder
- Highest education
- University of Washington
V K GADICo-Founder
Christopher KempCo-Founder
- Highest education
- Genetics · Beatson Institute For Cancer Research
Brady BernardCo-Founder
Investors · 2
- AletheaFund
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 15 (previous snapshot 22)
- Recorded funding
- US$12.80m · Series B · Feb 2020
- Founded
- 2008 · about 18 years old
- Stage
- Series B
- Focus
- Research services, Diversified
Funding over time
US$12.80m across 7 disclosed equity rounds
Darker bars = larger roundsFounders · 1
Theresa DeisherFounder & CEO
Team & hiring signals
LinkedIn headcount142-10
LinkedIn followers2,438
Technology
- PHP
- MySQL
- Nginx
- WordPress
- jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Fee-for-service
- Team size
- 14
- Recorded funding
- US$155.00m · Series B · Jan 2026
- Founded
- 2020 · about 6 years old
- Stage
- Series B
- Focus
- Drugs, Diversified, Cro
Funding over time
US$155.00m across 2 disclosed equity rounds
Darker bars = larger roundsFounders · 7
Jose SahelCo-Founder
Lyndon CruzCo-Founder
Thomas RehCo-Founder
Vanessa KingCo-Founder
- Highest education
- Doctor of Philosophy, Genetics · University of Cambridge
Pete CoffeyCo-Founder
Olivier GoureauCo-Founder
Deniz DalkaraCo-Founder
Investors · 10
- EQTFund
- F-Prime CapitalFund
- HillhouseFund
- QimingFund
Team & hiring signals
LinkedIn headcount451-200
LinkedIn followers2,508
Open roles0of 1 tracked · last posted Nov 2024
Technology
- PHP
- MySQL
- Nginx
- WordPress
- jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 13 (previous snapshot 12)
- Recorded funding
- US$2.46m · Seed · Sep 2023
- Founded
- 2020 · about 6 years old
- Stage
- Seed
- Focus
- Research services, Diversified
Funding over time
US$2.46m across 2 disclosed equity rounds
Darker bars = larger roundsFounders · 1
Colleen DelaneyFounder
- Highest education
- Doctor of medicine in medicine · Harvard Medical School
Team & hiring signals
LinkedIn headcount611-50
LinkedIn followers2,337
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Hardware
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Physical commerce
- Team size
- 13
- Recorded funding
- US$28.43m · Series B · Nov 2018
- Founded
- 2002 · about 24 years old
- Stage
- Series B
- Focus
- Medical devices, Therapies, Chemotherapy, Electrochemo therapy
Funding over time
US$28.43m across 9 disclosed equity rounds
Darker bars = larger roundsFounders · 1
Lisa Buttersex-Co-Founder
Team & hiring signals
LinkedIn headcount1311-50
LinkedIn followers896
Earlier recorded team132010, a different source
Patents
Patent filings81
Focus: Wireless electromagnetic coil systems for targeted cancer therapy, especially glioblastoma treatment.
CPC G01N37/005, A61N2/02, G01R33/032Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Social impactSoftwareHardware
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Fee-for-service
- Team size
- 10
- Recorded funding
- US$2.50m · Seed · Jun 2021
- Founded
- 2017 · about 9 years old
- Stage
- Seed
- Focus
- Applied genomics, Consumer genomics, Microbiomics, Medical devices
Funding over time
US$2.50m across 3 disclosed equity rounds
Darker bars = larger roundsFounders · 2
Thomas LendvayCo-Founder & Chief Medical Officer
Kathleen LendvayCo-founder, President and COO
- Highest education
- Bachelor's in economics · Rice University
Team & hiring signals
LinkedIn headcount162-10
LinkedIn followers436
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Consumer
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 10 (previous snapshot 15)
- Recorded funding
- US$2.65m · Seed · Apr 2021
- Founded
- 2019 · about 7 years old
- Stage
- Seed
- Focus
- In vitro diagnostic tests, Fertility, Pregnancy, Applied genomics
Funding over time
US$2.65m across 2 disclosed equity rounds
Darker bars = larger roundsFounders · 1
Elizabeth RuzzoFounder & CEO
Investors · 11
ASCENDFund- Concrete RoseFund
- Lux CapitalFund
M13 CompanyFund- Y CombinatorFund
- Anne WojcickiAngel
Team & hiring signals
LinkedIn headcount82-10
LinkedIn followers2,569
Technology
- AWS
- PHP
- MySQL
- Cloudflare
- HubSpot
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Advertising, Commission on transaction, Subscription
- Team size
- 8
- Recorded funding
- US$20k · Seed · Jan 2022
- Founded
- 2022 · about 4 years old
- Stage
- Seed
- Focus
- Research & development, Drug informatics, Scientific literature, Online search portals
Founders · 2
Gordon SilvermanCo-Founder
- Highest education
- MBA · Duke University
Mahek ChhatrapatiCo-Founder & CEO
- Highest education
- MBA · Duke University
Investors · 1
TechstarsFund
Team & hiring signals
Open roles0of 2 tracked · last posted Jan 2025
Technology
- AWS
- React
- Cloudflare
Amazon S3
Tailwind CSS
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Physical commerce
- Team size
- 6
- Recorded funding
- US$120k · Seed · Jan 2018
- Founded
- 2014 · about 12 years old
- Stage
- Seed
- Focus
- Research services, Biorepository
Founders · 2
Jenna StrullyCo-Founder
- Highest education
- Master's of business administration in marketing · University Of Washington - Michael G. Foster School Of Business
Alex JiaoCo-Founder & CEO
- Highest education
- Bioengineering · University of Washington
Investors · 2
- TechstarsFund
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Hardware
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 5
- Recorded funding
- US$1.72m · Seed · Jul 2015
- Founded
- 2012 · about 14 years old
- Stage
- Seed
- Focus
- Critical care, Infusion systems, Monitoring
Funding over time
US$1.72m across 2 disclosed equity rounds
Darker bars = larger roundsFounders · 2
Beth KolkoCo-Founder & CEO
Koji IntlekoferCo-Founder & CTO
- Highest education
- Master's of science in mechanical engineering · Georgia Institute Of Technology
Investors · 1
- Y CombinatorFund
Team & hiring signals
LinkedIn headcount42-10
LinkedIn followers608
Patents
Patent filings28
Focus: Medical infusion flow monitoring and RFID-based inventory tracking systems
CPC A61M5/1689, G01G17/04, G01F1/661Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Recently founded
Life sciences companies in Seattle founded in the last four years, newest first.
OncologyDeveloper of multi-payload antibody-drug conjugates for cancer treatment
Founded2024Series A
Founders · 2
Jerome KirkupCo-Founder & Chief Scientific Officer
Piers IngramCo-Founder & CEO
Life sciences platforms and toolsDeveloper of antibody therapeutics and vaccines addressing opioid dependence and overdose
Founded2024Unfunded
Founder · 1
Marco PFounder & Chief Scientific Officer (CSO)
Life sciences techDeveloper of software enabling biologists to analyze gene expression datasets
Founded2024Unfunded
Founders
Details not available
GenomicsProvider of AI-generated gene expression data for biological research purposes
Founded2023Series A
Founders · 2
Robert BradleyCo-Founder
Jeff LeekCo-Founder & CEO
OncologyDeveloper of de novo protein therapies for complex diseases treatment
Founded2023Seed
Founders · 4
Javier CastellanosCo-Founder & CTO
Bill ArthurCo-Founder & CEO
Hector RinconCo-Founder & CSO
Matthew BickCo-Founder & CEO
Life sciences techProvider of computational platform to develop protein therapeutics
Founded2023Seed
Founders · 4
George UedaCo-Founder & CTO
David BakerCo-Founder
James LazarovitsCo-Founder & CEO
Lance StewartCo-Founder
OphthalmologyDeveloper of AI-driven platform creating de novo genes and protein therapeutics
Founded2023Seed
Founders · 4
Roee FarberCo-Founder & CEO
Ori HassinCo-Founder
Ariel Ben-SassonCo-Founder and CTO
Ori ZelichovCo-Founder
Life sciences techDeveloper of an AI platform for life science research execution
Founded2023Series A
Founders · 2
Ryan KosaiCo-Founder & CTO
Nick EdwardsCo-Founder & CEO
Life sciences techAI-enabled software company that helps pharmaceutical scientists and researchers design and optimize in-vivo experiments for drug development
Founded2023Unfunded
Founders · 2
Colin SmallCo-Founder
Ian LevineCo-Founder & CEO
Nutraceuticals techProvider of a dietary supplement to manage sugar cravings
Founded2023Unfunded
Founders · 2
Tracy KomlosCo-Founder
Sarah StewartCo-Founder
OncologyDeveloper of cell therapies for cancer treatment
Founded2023Unfunded
Founders
Details not available
Life sciences techAI-powered key opinion leader management system for medical affairs professionals
Founded2022Seed
Founders · 2
Gordon SilvermanCo-Founder
Mahek ChhatrapatiCo-Founder & CEO
Software
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Physical commerce
- Team size
- Not available
- Recorded funding
- US$187.00m · Series A · Mar 2025
- Founded
- 2024 · about 2 years old
- Stage
- Series A
- Focus
- Autoimmune diseases, Diversified, Drugs
Founders · 2
Jerome KirkupCo-Founder & Chief Scientific Officer
Piers IngramCo-Founder & CEO
Investors · 10
- EDBIFund
- JeitoFund
- Novo HoldingsFund
- Omega FundsFund
- PlatanusFund
- SEEDS CapitalFund
Team & hiring signals
LinkedIn headcount1911-50
LinkedIn followers4,138
Open roles1of 2 tracked · last posted Feb 2026
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Physical commerce, Subscription
- Team size
- Not available
- Recorded funding
- None recorded
- Founded
- 2024 · about 2 years old
- Stage
- Unfunded
- Focus
- Diversified, Research services
Founders · 1
Marco PFounder & Chief Scientific Officer (CSO)
Team & hiring signals
LinkedIn headcount52-10
LinkedIn followers604
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
SaaSSoftware
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- Not available
- Recorded funding
- None recorded
- Founded
- 2024 · about 2 years old
- Stage
- Unfunded
- Focus
- Drug discovery, Genomics, Research & development, Sequencing analysis
Team & hiring signals
LinkedIn headcount1
LinkedIn followers5
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Artificial IntelligenceSoftware
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- Not available
- Recorded funding
- US$10.00m · Series A · Sep 2025
- Founded
- 2023 · about 3 years old
- Stage
- Series A
- Focus
- Research & development, Drug discovery, Genomics, Genomics services
Founders · 2
Robert BradleyCo-Founder
- Highest education
- The University of California
Jeff LeekCo-Founder & CEO
- Highest education
- University of Washington
Investors · 1
Team & hiring signals
LinkedIn headcount2111-50
LinkedIn followers1,899
Recent company signals
- Award AI Innovation of the Year — GeekWire
Technology
- Cloudflare
- HubSpot
Webflow- jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Software
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Physical commerce, Subscription
- Team size
- Not available
- Recorded funding
- US$12.70m · Seed · Nov 2025
- Founded
- 2023 · about 3 years old
- Stage
- Seed
- Focus
- Autoimmune diseases, Diversified, Drug discovery, Drugs
Founders · 4
Javier CastellanosCo-Founder & CTO
- Highest education
- Doctorates in biochemistry · University Of Washington
Bill ArthurCo-Founder & CEO
Hector RinconCo-Founder & CSO
Matthew BickCo-Founder & CEO
Investors · 8
- AlexandriaFund
ArgonauticFund
Pack VenturesFund- TakedaFund
Columbus Venture PartnersFund
Team & hiring signals
LinkedIn headcount2411-50
LinkedIn followers1,298
Technology
- PHP
- MySQL
- Cloudflare
- WordPress
- Bootstrap
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Software
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- Not available
- Recorded funding
- US$20.00m · Seed · Oct 2024
- Founded
- 2023 · about 3 years old
- Stage
- Seed
- Focus
- Drug discovery, Proteomics, Research & development
Founders · 4
George UedaCo-Founder & CTO
- Highest education
- BS · University of Washington
David BakerCo-Founder
- Highest education
- PhD · The University of California
James LazarovitsCo-Founder & CEO
- Highest education
- PhD · University of Toronto
Lance StewartCo-Founder
Investors · 7
- AlexandriaFund
- Duke UniversityFund
- Pack VenturesFund
- Sahsen VenturesFund
Cornucopian CapitalFund
Team & hiring signals
LinkedIn headcount2611-50
LinkedIn followers2,692
Technology
- AWS
- Angular
- TypeScript
- Cloudflare
- jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Artificial Intelligence
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- Not available
- Recorded funding
- US$4.00m · Seed · Sep 2024
- Founded
- 2023 · about 3 years old
- Stage
- Seed
- Focus
- Research & development, Drug discovery, Genomics, Drug development
Founders · 4
Roee FarberCo-Founder & CEO
- Highest education
- Doctor of Medicine · Ben-Gurion
Ori HassinCo-Founder
- Highest education
- Doctor of Philosophy · Weizmann Institute of Science
Ariel Ben-SassonCo-Founder and CTO
Ori ZelichovCo-Founder
Investors · 2
Team & hiring signals
LinkedIn headcount72-10
LinkedIn followers1,603
Recent company signals
- Partnership Partnership with MeiraGTx (Nasdaq: MGTX)
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
SaaSSoftware
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- Not available
- Recorded funding
- US$5.50m · Series A · Apr 2025
- Founded
- 2023 · about 3 years old
- Stage
- Series A
- Focus
- Drug informatics, Online search portals, Research & development, Scientific literature
Funding over time
US$5.50m across 2 disclosed equity rounds
Darker bars = larger roundsFounders · 2
Ryan KosaiCo-Founder & CTO
Nick EdwardsCo-Founder & CEO
Investors · 16
AI2 IncubatorFund- Alumni VenturesFund
AxialFund
Boost VCFund
Bow CapitalFund
Defined CapitalFund
Team & hiring signals
LinkedIn headcount802-10
LinkedIn followers4,614
Technology
- AWS
- Cloudflare
- HubSpot
- Amazon S3
- CloudFront
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Software
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 1
- Recorded funding
- None recorded
- Founded
- 2023 · about 3 years old
- Stage
- Unfunded
- Focus
- Ai based, Cheminformatics, Drug discovery, Lead discovery
Founders · 2
Colin SmallCo-Founder
Ian LevineCo-Founder & CEO
Team & hiring signals
LinkedIn headcount72-10
LinkedIn followers639
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Consumer
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product
- Team size
- Not available
- Recorded funding
- None recorded
- Founded
- 2023 · about 3 years old
- Stage
- Unfunded
- Focus
- Dietary supplements, Disease specific, Diabetes
Founders · 2
Tracy KomlosCo-Founder
Sarah StewartCo-Founder
Team & hiring signals
LinkedIn headcount42-10
LinkedIn followers79
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Fee-for-service
- Team size
- Not available
- Recorded funding
- None recorded
- Founded
- 2023 · about 3 years old
- Stage
- Unfunded
- Focus
- Diversified, Drugs
Team & hiring signals
LinkedIn headcount3111-50
LinkedIn followers5,413
Open roles3of 15 tracked · last posted Mar 2026
- Hiring: Director · Seattle, Washington
- Hiring: Director/Senior Director Clinical Sciences · Greater Seattle Area
- Hiring: Director/Sr Director of Clincal Science · Seattle
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Advertising, Commission on transaction, Subscription
- Team size
- 8
- Recorded funding
- US$20k · Seed · Jan 2022
- Founded
- 2022 · about 4 years old
- Stage
- Seed
- Focus
- Research & development, Drug informatics, Scientific literature, Online search portals
Founders · 2
Gordon SilvermanCo-Founder
- Highest education
- MBA · Duke University
Mahek ChhatrapatiCo-Founder & CEO
- Highest education
- MBA · Duke University
Investors · 1
- TechstarsFund
Team & hiring signals
Open roles0of 2 tracked · last posted Jan 2025
Technology
- AWS
- React
- Cloudflare
- Amazon S3
- Tailwind CSS
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Most covered in the news
Companies with the most distinct news events in the last 24 months across the business press Fliar tracks.
Infectious diseasesProvider of clinical diagnostics, and drug discovery for immune diseases
News events · last 24 months74Across tracked business press
Founders · 2
Harlan Robinsco-founder and chief Scientific Officer
Chad RobinsPresident, CEO & Co-Founder
NeurologyDeveloper of plant-based alkaloid for treating smoking cessation
News events · last 24 months52Across tracked business press
Leadership · 2
John BencichCEO
Richard StewartChairman & CEO
Infectious diseasesDeveloper of biological drugs for the treatment of infectious diseases
News events · last 24 months35Across tracked business press
Founder · 1
Brian FinrowCEO & Founder
OncologyDeveloper of engineered cell therapies for treating various human diseases
News events · last 24 months27Across tracked business press
Founders · 4
Steve HarrCo-Founder & CEO
Michael MeeCo-Founder
Jacob RubensCo-Founder
Geoffrey MaltzahnCo-Founder
Wearable technologyDeveloper of non-invasive technology for identifying and measuring molecules
News events · last 24 months17Across tracked business press
Founder · 1
Ron EricksonFounder & Chairman
Life sciences platforms and toolsDeveloper of proteomics platform for drug development
News events · last 24 months16Across tracked business press
Founders · 2
Sujal PatelCo-Founder & CEO
Parag MallickCo-Founder
ImmunotherapyDeveloping T-cell cytotoxicity targeted immunotherapeutic drugs primarily for cancer and hematology
News events · last 24 months14Across tracked business press
Leadership · 1
Marvin WhitePresident and CEO
Women healthDeveloper of drugs for treating breast cancer
News events · last 24 months13Across tracked business press
Founder · 1
Steven QuayFounder & CEO
OncologyWe are a healthcare company focused on the development and marketing of novel cellular and molecular diagnostic risk assessment products for breast cancer.
News events · last 24 months13Across tracked business press
Founders
Details not available
Life sciences platforms and toolsDeveloper of therapies for the treatment of Idiopathic Pulmonary Fibrosis
News events · last 24 months10Across tracked business press
Founders · 2
Richard G. VincentCo-Founder & CFO
Mark SurberFounder
Life sciences platforms and toolsDeveloper of enzyme design technology to bridge the gap by creating synthetic enzymes
News events · last 24 months8Across tracked business press
Founders · 3
David BakerCo-Founder
Daniela Grabs-RothlisbergerCo-Founder
Alexandre ZanghelliniCo-Founder & CEO
NeurologyDeveloper of drugs for neurodegenerative diseases
News events · last 24 months7Across tracked business press
Leadership · 1
Mark LittonPresident and CEO
Has made acquisitions
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 609
- Recorded funding
- US$419.15m · Series F · Jan 2018
- Founded
- 2009 · about 17 years old
- Stage
- Public
- Focus
- Drugs, Viral, Diversified
Funding over time
US$419.15m across 8 disclosed equity rounds
Darker bars = larger roundsFounders · 2
Harlan Robinsco-founder and chief Scientific Officer
- Highest education
- Bachelor's, Physics · Harvard University
Chad RobinsPresident, CEO & Co-Founder
- Highest education
- Master's of business administration in marketing · The Wharton School
Investors · 12
- AlexandriaFund
- BD BiosciencesFund
- Casdin CapitalFund
- CelgeneFund
- IlluminaFund
- LabCorpFund
- MatrixFund
Team & hiring signals
LinkedIn headcount643501-1,000
LinkedIn followers34,871
Earlier recorded team6092022, a different source
Open roles4of 9 tracked · last posted Feb 2026
Recent company signals
- Partnership Partnership with OpenFold Consortium
- Partnership Partnership with BLOODPAC
- Partnership Partnership with Scientist.com
Patents
Patent filings351
Focus: Immune repertoire sequencing for diagnostics, vaccine response, and engineered T‑cell therapies
CPC C12Q1/6881, C12Q1/6886, C12Q1/6869Technology
- PHP
- MySQL
- Nginx
- WordPress
- jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Has made acquisitions
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Physical commerce
- Team size
- 25
- Recorded funding
- None recorded
- Founded
- 1991 · about 35 years old
- Stage
- Public
- Focus
- Drugs, Psychiatric, Addiction
Leadership · 2
John BencichCEO
- Highest education
- Master's in business administration · Seattle University
Richard StewartChairman & CEO
Team & hiring signals
LinkedIn headcount4511-50
LinkedIn followers3,190
Earlier recorded team252022, a different source
Recent company signals
- Leadership Hired a CFO and CSO
- Leadership Hired a Board of Directors member
- Leadership Hired a Chief Executive Officer
Technology
- PHP
- MySQL
- Cloudflare
- WordPress
- Bootstrap
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Physical commerce
- Team size
- 67 (previous snapshot 92)
- Recorded funding
- US$73.00m · Series C · Sep 2023
- Founded
- 2011 · about 15 years old
- Stage
- Series C
- Focus
- Drugs, Diversified
Funding over time
US$73.00m across 5 disclosed equity rounds
Darker bars = larger roundsFounders · 1
Brian FinrowCEO & Founder
Investors · 4
- WestRiver GroupFund
- Avista DevelopmentFund
Team & hiring signals
LinkedIn headcount10451-200
LinkedIn followers8,308
Recent company signals
- Leadership Hired a clinical development team member
- Leadership Hired a Executive Vice President (EVP)
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Has made acquisitions
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Physical commerce, Fee-for-service
- Team size
- 328 (previous snapshot 570)
- Recorded funding
- US$821.00m · Series D · Jun 2020
- Founded
- 2018 · about 8 years old
- Stage
- Public
- Focus
- Applied genomics, Clinical genomics, Therapeutics, Drugs
Founders · 4
Steve HarrCo-Founder & CEO
Michael MeeCo-Founder
- Highest education
- Biomedical Engineering · Boston University
Jacob RubensCo-Founder
- Highest education
- Healthcare · Mit Sloan School Of Management
Geoffrey MaltzahnCo-Founder
- Highest education
- Doctor of Engineering · MIT
Investors · 11
- Baillie GiffordFund
- CPP InvestmentsFund
- F-Prime CapitalFund
Team & hiring signals
LinkedIn headcount253201-500
LinkedIn followers52,875
Earlier recorded team3282023, a different source
Open roles2of 8 tracked · last posted Jan 2026
Patents
Patent filings361
Focus: Engineered cell therapies and gene delivery platforms for regenerative medicine.
CPC A61K40/11, C12N15/86, C12N5/0676Technology
- AWS
- PHP
- MySQL
- Cloudflare
- WordPress
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
ConsumerSoftwareHardwareHas made acquisitions
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Physical commerce
- Team size
- 11
- Recorded funding
- None recorded
- Founded
- 2003 · about 23 years old
- Stage
- Public
- Focus
- Health and wellness devices, Diabetes monitoring, Medical devices, Monitoring devices
Founders · 1
Ron EricksonFounder & Chairman
- Highest education
- M.A, American Studies · University of Wyoming
Team & hiring signals
LinkedIn headcount811-50
LinkedIn followers3,270
Earlier recorded team112023, a different source
Patents
Patent filings217
Focus: Non‑invasive RF/microwave analyte sensing for medical and infrastructure diagnostics
CPC A61B5/0507, A61B5/14532, G01N22/00Technology
Google Cloud- React
- Sentry
- Bootstrap
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 134 (previous snapshot 120)
- Recorded funding
- US$453.26m · Series C · Feb 2021
- Founded
- 2016 · about 10 years old
- Stage
- Public
- Focus
- Research services, Proteomics
Funding over time
US$453.26m across 3 disclosed equity rounds
Darker bars = larger roundsFounders · 2
Sujal PatelCo-Founder & CEO
- Highest education
- Bachelor's in computer science · University Of Maryland
Parag MallickCo-Founder
- Highest education
- PhD · University of California
Investors · 7
Team & hiring signals
LinkedIn headcount15051-200
LinkedIn followers14,297
Earlier recorded team1342022, a different source
Open roles0of 4 tracked · last posted Oct 2025
Patents
Patent filings90
Focus: Multiplexed single‑molecule protein analysis using nano‑ and micro‑array platforms
CPC G01N33/54353, G16B40/10, C07K1/047Technology
- PHP
- MySQL
- Cloudflare
- HubSpot
- WordPress
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Physical commerce
- Team size
- 45 (previous snapshot 71)
- Recorded funding
- None recorded
- Founded
- 2016 · about 10 years old
- Stage
- Public
- Focus
- Drugs, Diversified
Leadership · 1
Marvin WhitePresident and CEO
- Highest education
- Master's of business administration in finance · Indiana University Bloomington
Team & hiring signals
LinkedIn headcount5551-200
LinkedIn followers4,453
Earlier recorded team452022, a different source
Recent company signals
- Leadership Hired a SVP & Chief Scientific Officer
Technology
- PHP
- MySQL
- WordPress
- Bootstrap
- jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Physical commerce
- Team size
- 10
- Recorded funding
- US$6.77m · Series A · Jun 2011
- Founded
- 2009 · about 17 years old
- Stage
- Public
- Focus
- Implants, Drugs, Breast cancer, Cancer
Funding over time
US$6.77m across 2 disclosed equity rounds
Darker bars = larger roundsFounders · 1
Steven QuayFounder & CEO
- Highest education
- Stanford University Graduate School Of Business
Team & hiring signals
LinkedIn headcount3151-200
LinkedIn followers6,619
Earlier recorded team102022, a different source
Patents
Patent filings166
Focus: Sustained‑release endocrine modulators and pulmonary drug formulations using heparin/N‑acetylcysteine.
CPC A61K31/138, C07C217/18, A61K9/0014Technology
- Google Cloud
- PHP
- MySQL
- Cloudflare
- WordPress
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Physical commerce
- Team size
- 22 (previous snapshot 21)
- Recorded funding
- None recorded
- Founded
- 2009 · about 17 years old
- Stage
- Not available
- Focus
- Breast cancer, Diversified, In vitro diagnostic tests, In vitro diagnostics tests
Team & hiring signals
LinkedIn headcount3351-200
LinkedIn followers6,474
Patents
Patent filings63
Focus: Patents concentrated in computing, sensing & instrumentation
CPC G01N33/57515, A61K31/138, C12Q1/6886Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Physical commerce
- Team size
- 24 (previous snapshot 35)
- Recorded funding
- US$388.86m · Series D · Jul 2025
- Founded
- 2011 · about 15 years old
- Stage
- Public
- Focus
- Research services, Diversified, Drugs, Fibrosis
Funding over time
US$388.86m across 5 disclosed equity rounds
Darker bars = larger roundsFounders · 2
Richard G. VincentCo-Founder & CFO
Mark SurberFounder
Investors · 20
- CitadelFund
- F-Prime CapitalFund
- Novo HoldingsFund
Team & hiring signals
LinkedIn headcount6511-50
LinkedIn followers9,923
Open roles1of 2 tracked · last posted Nov 2025
Recent company signals
- Milestone target enrollment ahead of schedule target enrollment in Phase 2b MIST trial of inhaled pirfenidone (AP01) in progressive pulmonary fibrosis
Technology
- AWS
- PHP
- MySQL
- Nginx
- WordPress
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Physical commerce
- Team size
- 60
- Recorded funding
- US$95.21m · Series B · Aug 2025
- Founded
- 2008 · about 18 years old
- Stage
- Series B
- Focus
- Research services, Proteomics
Funding over time
US$94.96m across 7 disclosed equity rounds
Darker bars = larger roundsFounders · 3
David BakerCo-Founder
Daniela Grabs-RothlisbergerCo-Founder
- Highest education
- PhD · University of Zurich
Alexandre ZanghelliniCo-Founder & CEO
- Highest education
- PhD · University of Washington
Investors · 17
- BungeFund
- Casdin CapitalFund
- OS FundFund
Team & hiring signals
LinkedIn headcount7951-200
LinkedIn followers9,395
Earlier recorded team602022, a different source
Recent company signals
- Leadership Hired a Chief Operating Officer
- Partnership Partnership with KENT Specialty Milling
- Partnership Partnership with MANE
Patents
Patent filings85
Focus: Enzymatic synthesis and modification of steviol glycoside sweeteners
CPC C12P19/56, C12N9/1051, C12N9/90Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Physical commerce
- Team size
- 62 (previous snapshot 50)
- Recorded funding
- US$121.04m · Series B · Jun 2020
- Founded
- 2011 · about 15 years old
- Stage
- Public
- Focus
- Drugs, Neurodegenerative, Diversified
Funding over time
US$121.04m across 7 disclosed equity rounds
Darker bars = larger roundsLeadership · 1
Mark LittonPresident and CEO
Investors · 18
+10 moreTeam & hiring signals
LinkedIn headcount5651-200
LinkedIn followers7,660
Earlier recorded team622022, a different source
Recent company signals
- Leadership Hired a Board of Directors
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Explore Seattle life sciences companies by sub-sector
The most common specialisations among life sciences companies in Seattle. Open a company to see what it sells, who runs it and how far it has come.
Life sciences platforms and tools · 50
50 life sciences companies in Seattle work in life sciences platforms and tools. Shown: the best-documented.
Life sciences platforms and toolsDeveloper of proteomics platform for drug development
Revenue modelSubscription
Founders · 2
Sujal PatelCo-Founder & CEO
Parag MallickCo-Founder
Life sciences platforms and toolsDeveloper of RNA-sequencing solution-based transcriptome kit to analyze health data
Revenue modelSubscription
Founders · 2
Geoff KrummelCo-Founder
Alex RosenbergCo-Founder & CEO
Life sciences platforms and toolsIntegrated system to reduce blood culture sample contamination
Revenue modelSubscription
Founders · 2
Gregory BullingtonCo-Founder & CEO
Richard PattonCo-Founder & Medical Director
Life sciences platforms and toolsDeveloper of enzyme design technology to bridge the gap by creating synthetic enzymes
Revenue modelPhysical commerce
Founders · 3
David BakerCo-Founder
Daniela Grabs-RothlisbergerCo-Founder
Alexandre ZanghelliniCo-Founder & CEO
GenomicsDeveloper of technologies for the analysis of rare and single cells in the blood
Revenue modelSubscription
Leadership · 1
Joseph VictorPresident & CEO
Life sciences platforms and toolsDeveloper of cell-based tool for the measurements of protein interactions
Revenue modelSubscription
Founder · 1
Randolph LopezCo-founder & CTO
Life sciences platforms and toolsDeveloper of biosensors to detect viral proteins, toxins, antibodies, and other molecules
Revenue modelSubscription
Founders · 2
Alfredo RubioCo-Founder
Daniel ManzanoCo-Founder & CEO
Life sciences platforms and toolsDeveloper of therapies for the treatment of Idiopathic Pulmonary Fibrosis
Revenue modelE-commerce - product / Physical commerce
Founders · 2
Richard G. VincentCo-Founder & CFO
Mark SurberFounder
Life sciences platforms and toolsProvider of laboratory and computational services and products
Revenue modelSubscription
Founders · 2
Shawn SullivanCo-Founder
Ivan LiachkoCo-Founder
Life sciences platforms and toolsTranslational oncology company pioneering drug development with its CIVO platform
Revenue modelE-commerce - product / Physical commerce
Founder · 1
Jim OlsonFounder and Chairman
Life sciences platforms and toolsSmall molecule and biologics for regenerative medicine, oncology, and fully human biologics
Revenue modelSubscription
Founder · 1
Theresa DeisherFounder & CEO
Life sciences platforms and toolsProvider of progenitor blood and immune cells for clinical application
Revenue modelSubscription
Founder · 1
Colleen DelaneyFounder
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 134 (previous snapshot 120)
- Recorded funding
- US$453.26m · Series C · Feb 2021
- Founded
- 2016 · about 10 years old
- Stage
- Public
- Focus
- Research services, Proteomics
Funding over time
US$453.26m across 3 disclosed equity rounds
Darker bars = larger roundsFounders · 2
Sujal PatelCo-Founder & CEO
- Highest education
- Bachelor's in computer science · University Of Maryland
Parag MallickCo-Founder
- Highest education
- PhD · University of California
Investors · 7
Team & hiring signals
LinkedIn headcount15051-200
LinkedIn followers14,297
Earlier recorded team1342022, a different source
Open roles0of 4 tracked · last posted Oct 2025
Patents
Patent filings90
Focus: Multiplexed single‑molecule protein analysis using nano‑ and micro‑array platforms
CPC G01N33/54353, G16B40/10, C07K1/047Technology
- PHP
- MySQL
- Cloudflare
- HubSpot
- WordPress
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Has made acquisitions
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 107 (previous snapshot 110)
- Recorded funding
- US$100.26m · Series C · Dec 2023
- Founded
- 2018 · about 8 years old
- Stage
- Series C
- Focus
- Enabling technologies, Kits and reagents, Detection and quantification, Research reagents and kits
Funding over time
US$100.26m across 5 disclosed equity rounds
Darker bars = larger roundsFounders · 2
Geoff KrummelCo-Founder
Alex RosenbergCo-Founder & CEO
- Highest education
- BA · Washington University in St. Louis
Investors · 7
- LogosFund
- Marshall WaceFund
- Sahsen VenturesFund
- Soleus CapitalFund
- Saras CapitalFund
Team & hiring signals
LinkedIn headcount13551-200
LinkedIn followers26,097
Open roles4of 11 tracked · last posted Jul 2026
Technology
- AWS
- PHP
- MySQL
- Cloudflare
- Sentry
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 77
- Recorded funding
- US$102.86m · Series C · Jul 2022
- Founded
- 2006 · about 20 years old
- Stage
- Series C
- Focus
- Instruments, Contaminent detection
Funding over time
US$102.86m across 7 disclosed equity rounds
Darker bars = larger roundsFounders · 2
Gregory BullingtonCo-Founder & CEO
- Highest education
- Business Administration · University Of Washington - Michael G. Foster School Of Business
Richard PattonCo-Founder & Medical Director
Investors · 7
- RTW InvestmentsFund
- SectoralFund
- Canepa HealthcareFund
Team & hiring signals
LinkedIn headcount8151-200
LinkedIn followers4,810
Earlier recorded team772021, a different source
Patents
Patent filings433
Focus: Medical fluid handling devices for sampling, control, and contamination‑free delivery
CPC A61B5/150221, A61B5/150251, A61B10/0045Technology
- PHP
- MySQL
- Cloudflare
- Salesforce
- Zendesk
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Physical commerce
- Team size
- 60
- Recorded funding
- US$95.21m · Series B · Aug 2025
- Founded
- 2008 · about 18 years old
- Stage
- Series B
- Focus
- Research services, Proteomics
Funding over time
US$94.96m across 7 disclosed equity rounds
Darker bars = larger roundsFounders · 3
David BakerCo-Founder
Daniela Grabs-RothlisbergerCo-Founder
- Highest education
- PhD · University of Zurich
Alexandre ZanghelliniCo-Founder & CEO
- Highest education
- PhD · University of Washington
Investors · 17
- BungeFund
- Casdin CapitalFund
- OS FundFund
Team & hiring signals
LinkedIn headcount7951-200
LinkedIn followers9,395
Earlier recorded team602022, a different source
Recent company signals
- Leadership Hired a Chief Operating Officer
- Partnership Partnership with KENT Specialty Milling
- Partnership Partnership with MANE
Patents
Patent filings85
Focus: Enzymatic synthesis and modification of steviol glycoside sweeteners
CPC C12P19/56, C12N9/1051, C12N9/90Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 54
- Recorded funding
- US$114.33m · Series C · Jun 2024
- Founded
- 2009 · about 17 years old
- Stage
- Series C
- Focus
- Enabling technologies, Kits and reagents, Detection and quantification, Research reagents and kits
Funding over time
US$114.33m across 6 disclosed equity rounds
Darker bars = larger roundsLeadership · 1
Joseph VictorPresident & CEO
Investors · 9
- 5AM VenturesFund
- AgilentFund
- F-Prime CapitalFund
- LogosFund
- Bill BurkothAngel
Team & hiring signals
LinkedIn headcount6451-200
LinkedIn followers6,444
Earlier recorded team542022, a different source
Open roles1of 1 tracked · last posted Mar 2026
Patents
Patent filings266
Focus: Multiplexed fluorescence microscopy with spectral crosstalk reduction and angle-tuned illumination.
CPC B01L3/50215, B01L3/5021, G02B21/26Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 39 (previous snapshot 43)
- Recorded funding
- US$45.24m · Series A · Jul 2023
- Founded
- 2017 · about 9 years old
- Stage
- Series A
- Focus
- Research services, Proteomics
Funding over time
US$45.24m across 3 disclosed equity rounds
Darker bars = larger roundsFounders · 1
Randolph LopezCo-founder & CTO
- Highest education
- Bioengineering · University Of Washington
Investors · 9
- BOOMFund
- Lux CapitalFund
- OS FundFund
- Sahsen VenturesFund
Team & hiring signals
LinkedIn headcount4911-50
LinkedIn followers12,603
Earlier recorded team392022, a different source
Recent company signals
- Award 2026 Alumni Entrepreneurs of the year — University of Washington's Buerk Center for Entrepreneurship
- Launch Launched Synthetic Epitope Atlas (SEP) (antibodies-antigen structural data generation)
Technology
- React
- Netlify
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 27
- Recorded funding
- US$25.00m · Seed · Aug 2022
- Founded
- 2021 · about 5 years old
- Stage
- Seed
- Focus
- Instruments, Biosensors
Founders · 2
Alfredo RubioCo-Founder
Daniel ManzanoCo-Founder & CEO
Investors · 7
MatrixFund- Pack VenturesFund
- Sahsen VenturesFund
Team & hiring signals
LinkedIn headcount2711-50
LinkedIn followers4,488
Recent company signals
- Launch Launched LuxLink (antibodies assays)
- Leadership Hired a Board of Directors
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Physical commerce
- Team size
- 24 (previous snapshot 35)
- Recorded funding
- US$388.86m · Series D · Jul 2025
- Founded
- 2011 · about 15 years old
- Stage
- Public
- Focus
- Research services, Diversified, Drugs, Fibrosis
Funding over time
US$388.86m across 5 disclosed equity rounds
Darker bars = larger roundsFounders · 2
Richard G. VincentCo-Founder & CFO
Mark SurberFounder
Investors · 20
- CitadelFund
- F-Prime CapitalFund
- Novo HoldingsFund
Team & hiring signals
LinkedIn headcount6511-50
LinkedIn followers9,923
Open roles1of 2 tracked · last posted Nov 2025
Recent company signals
- Milestone target enrollment ahead of schedule target enrollment in Phase 2b MIST trial of inhaled pirfenidone (AP01) in progressive pulmonary fibrosis
Technology
- AWS
- PHP
- MySQL
- Nginx
- WordPress
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 19 (previous snapshot 34)
- Recorded funding
- US$5.75m · Series A · Mar 2023
- Founded
- 2015 · about 11 years old
- Stage
- Series A
- Focus
- Research services, Genomics, Next generation sequencing (ngs), Enabling technologies
Funding over time
US$5.75m across 2 disclosed equity rounds
Darker bars = larger roundsFounders · 2
Shawn SullivanCo-Founder
Ivan LiachkoCo-Founder
- Highest education
- Doctorates in genetics · Cornell University
Investors · 2
Team & hiring signals
LinkedIn headcount1411-50
LinkedIn followers6,752
Earlier recorded team192021, a different source
Patents
Patent filings22
Focus: Genomic sequencing analytics, chromosome conformation capture, and lysin-based antibacterial therapeutics.
CPC G16B20/20, C12N15/1006, C12Q1/6806Technology
- PHP
- MySQL
- HubSpot
- WordPress
- jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Physical commerce
- Team size
- 17 (previous snapshot 15)
- Recorded funding
- US$32.39m · Series E · Mar 2021
- Founded
- 2008 · about 18 years old
- Stage
- Series E
- Focus
- Research assays, Drug discovery, Immunoassays
Funding over time
US$32.39m across 5 disclosed equity rounds
Darker bars = larger roundsFounders · 1
Jim OlsonFounder and Chairman
- Highest education
- Marketing · University of Derby
Investors · 5
- CelgeneFund
- LabCorpFund
- TakedaFund
- Takeda VenturesFund
Team & hiring signals
LinkedIn headcount1011-50
LinkedIn followers2,124
Earlier recorded team172022, a different source
Patents
Patent filings90
Focus: Oncology combination drugs and low-profile multi-agent injection delivery systems
CPC A61K31/4025, A61M5/3298, A61K31/40Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 15 (previous snapshot 22)
- Recorded funding
- US$12.80m · Series B · Feb 2020
- Founded
- 2008 · about 18 years old
- Stage
- Series B
- Focus
- Research services, Diversified
Funding over time
US$12.80m across 7 disclosed equity rounds
Darker bars = larger roundsFounders · 1
Theresa DeisherFounder & CEO
Team & hiring signals
LinkedIn headcount142-10
LinkedIn followers2,438
Technology
- PHP
- MySQL
- Nginx
- WordPress
- jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 13 (previous snapshot 12)
- Recorded funding
- US$2.46m · Seed · Sep 2023
- Founded
- 2020 · about 6 years old
- Stage
- Seed
- Focus
- Research services, Diversified
Funding over time
US$2.46m across 2 disclosed equity rounds
Darker bars = larger roundsFounders · 1
Colleen DelaneyFounder
- Highest education
- Doctor of medicine in medicine · Harvard Medical School
Team & hiring signals
LinkedIn headcount611-50
LinkedIn followers2,337
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Oncology · 34
34 life sciences companies in Seattle work in oncology. Shown: the best-documented.
OncologyDeveloper of engineered cell therapies for treating various human diseases
Revenue modelPhysical commerce / Fee-for-service
Founders · 4
Steve HarrCo-Founder & CEO
Michael MeeCo-Founder
Jacob RubensCo-Founder
Geoffrey MaltzahnCo-Founder
OncologyDeveloper of cancer therapeutics
Revenue modelSubscription
Founders · 3
Michael JensenCo-Founder
Andrew ScharenbergCo-Founder & CEO
Ryan CrismanCo-Founder
OncologyManufacturer of cytokine based drugs
Revenue modelPhysical commerce / Subscription
Founder · 1
John MulliganFounder & CEO
OncologyDeveloper of T-cell therapies for cancer treatment
Revenue modelSubscription
Founder · 1
Scott BoykenCo-Founder, Chief Technology Officer
OncologyDeveloper of immunotherapies for the treatment of cancer
Revenue modelSubscription
Founder · 1
Clifford StocksFounder & CEO
OncologyBiotechnology company improving cancer patient lives through Tumor Paint technology
Revenue modelSubscription
Leadership · 1
Heather FranklinPresident and CEO
OncologyProvider of precision medicine platform based on patient-derived organoids
Revenue modelFee-for-service
Founders · 5
Carla GrandoriCo-Founder & CEO
Eduardo MendezCo-Founder
V K GADICo-Founder
Christopher KempCo-Founder
Brady BernardCo-Founder
ImmunotherapyDiscovering human monoclonal antibodies for safe and effective therapeutic product development
Revenue modelSubscription
Leadership · 1
Clifford J StocksCEO
ImmunotherapyStealth mode immuno-oncology biotech startup
Revenue modelSubscription
Founder · 1
Peter ThompsonCo-Founder
OncologyProvider of drug discovery platform for gene regulators
Revenue modelSubscription
Founders · 2
Alex FederationCo-Founder & CEO
Lindsay PinoCo-Founder and CTO
OncologyDeveloper of radiofrequency based devices for treatment of cancers
Revenue modelPhysical commerce
Founders · 3
Bennett M. ButtersFounder
Kenneth FergusonCo-Founder & CSO
Xavier A. FigueroaCo-Founder & Director
NanotechnologyDeveloper of lipid nanoparticle and plasmid DNA for cancer therapy
Revenue modelFee-for-service
Founders · 3
John LewisCo-Founder
Gary HudsonCo-Founder
Matthew ScholzCo-Founder & CEO
Has made acquisitions
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Physical commerce, Fee-for-service
- Team size
- 328 (previous snapshot 570)
- Recorded funding
- US$821.00m · Series D · Jun 2020
- Founded
- 2018 · about 8 years old
- Stage
- Public
- Focus
- Applied genomics, Clinical genomics, Therapeutics, Drugs
Founders · 4
Steve HarrCo-Founder & CEO
Michael MeeCo-Founder
- Highest education
- Biomedical Engineering · Boston University
Jacob RubensCo-Founder
- Highest education
- Healthcare · Mit Sloan School Of Management
Geoffrey MaltzahnCo-Founder
- Highest education
- Doctor of Engineering · MIT
Investors · 11
- Baillie GiffordFund
- CPP InvestmentsFund
- F-Prime CapitalFund
Team & hiring signals
LinkedIn headcount253201-500
LinkedIn followers52,875
Earlier recorded team3282023, a different source
Open roles2of 8 tracked · last posted Jan 2026
Patents
Patent filings361
Focus: Engineered cell therapies and gene delivery platforms for regenerative medicine.
CPC A61K40/11, C12N15/86, C12N5/0676Technology
- AWS
- PHP
- MySQL
- Cloudflare
- WordPress
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 168 (previous snapshot 189)
- Recorded funding
- US$363.00m · Series C · Jan 2025
- Founded
- 2019 · about 7 years old
- Stage
- Series C
- Focus
- Drugs, Diversified
Funding over time
US$363.00m across 3 disclosed equity rounds
Darker bars = larger roundsFounders · 3
Michael JensenCo-Founder
Andrew ScharenbergCo-Founder & CEO
- Highest education
- The University of North Carolina
Ryan CrismanCo-Founder
- Highest education
- PhD · University of Colorado Boulder
Investors · 18
- AlexandriaFund
- Casdin CapitalFund
- DCVCFund
Team & hiring signals
LinkedIn headcount23751-200
LinkedIn followers23,592
Open roles5of 26 tracked · last posted Jun 2026
Recent company signals
- Leadership Hired a Board of Directors
- Award Company of the Year — Colorado BioScience Association
- Partnership Partnership with Nona Biosciences
- Milestone first in vivo CAR T cell therapy to achieve this milestone FDA Fast Track designation for CD19 in vivo CAR T cell therapy UB-VV111
Patents
Patent filings132
Focus: Lentiviral vector manufacturing and engineered stem cell therapies for immuno‑oncology
CPC C12N15/86, C12N5/0646, A61K40/31Technology
- PHP
- MySQL
- Nginx
- WordPress
- jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Physical commerce, Subscription
- Team size
- 54 (previous snapshot 29)
- Recorded funding
- US$119.91m · Series B · Apr 2026
- Founded
- 2021 · about 5 years old
- Stage
- Series B
- Focus
- Drugs, Diversified, Immuno oncology
Funding over time
US$119.91m across 2 disclosed equity rounds
Darker bars = larger roundsFounders · 1
John MulliganFounder & CEO
Investors · 6
- 3x5 PartnersFund
- Codon CapitalFund
- RocheFund
- Vivo CapitalFund
Team & hiring signals
LinkedIn headcount2511-50
LinkedIn followers5,910
Earlier recorded team542022, a different source
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 48 (previous snapshot 55)
- Recorded funding
- US$174.00m · Series B · Jul 2024
- Founded
- 2020 · about 6 years old
- Stage
- Series B
- Focus
- Drugs, Diversified
Funding over time
US$174.00m across 2 disclosed equity rounds
Darker bars = larger roundsFounders · 1
Scott BoykenCo-Founder, Chief Technology Officer
- Highest education
- Doctorates in biology · Iowa State University
Investors · 16
- AlexandriaFund
- Artis VenturesFund
- CitadelFund
Team & hiring signals
LinkedIn headcount7351-200
LinkedIn followers7,168
Earlier recorded team482022, a different source
Open roles0of 1 tracked · last posted Oct 2025
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 33
- Recorded funding
- US$149.62m · Series D · Apr 2025
- Founded
- 2015 · about 11 years old
- Stage
- Series D
- Focus
- Drugs, Diversified, Immuno oncology
Funding over time
US$149.62m across 8 disclosed equity rounds
Darker bars = larger roundsFounders · 1
Clifford StocksFounder & CEO
- Highest education
- MBA, Leadership · The University of Chicago Booth School of Business
Investors · 18
- AlexandriaFund
- BaxaltaFund
- Bering CapitalFund
- CanaanFund
- Helvetic TrustFund
- MD AndersonFund
Team & hiring signals
LinkedIn headcount102-10
LinkedIn followers1,323
Earlier recorded team332021, a different source
Patents
Patent filings56
Focus: LILRB2 immune‑checkpoint antibodies for cancer immunotherapy
CPC C07K16/2896, C07K16/2803, A61K39/3955Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Social impactSoftwareHas made acquisitions
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 27 (previous snapshot 34)
- Recorded funding
- US$123.70m · Series D · Feb 2024
- Founded
- 2010 · about 16 years old
- Stage
- Series D
- Focus
- Drugs, Diversified
Funding over time
US$123.70m across 12 disclosed equity rounds
Darker bars = larger roundsLeadership · 1
Heather FranklinPresident and CEO
Team & hiring signals
LinkedIn headcount1211-50
LinkedIn followers1,856
Earlier recorded team272022, a different source
Patents
Patent filings157
Focus: Patents concentrated in chemistry & materials
CPC C07K14/43522, C07K14/47, A61B1/043Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Fee-for-service
- Team size
- 26 (previous snapshot 46)
- Recorded funding
- US$27.35m · Series A · Mar 2023
- Founded
- 2015 · about 11 years old
- Stage
- Series A
- Focus
- In-vitro diagnostic tests, Pan cancer
Funding over time
US$27.35m across 5 disclosed equity rounds
Darker bars = larger roundsFounders · 5
Carla GrandoriCo-Founder & CEO
- Highest education
- PhD · Rockefeller University
Eduardo MendezCo-Founder
- Highest education
- University of Washington
V K GADICo-Founder
Christopher KempCo-Founder
- Highest education
- Genetics · Beatson Institute For Cancer Research
Brady BernardCo-Founder
Investors · 2
- AletheaFund
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Software
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 19
- Recorded funding
- US$61.16m · Series B · May 2015
- Founded
- 2004 · about 22 years old
- Stage
- Series B
- Focus
- Drugs, Diversified, Viral
Funding over time
US$61.16m across 7 disclosed equity rounds
Darker bars = larger roundsLeadership · 1
Clifford J StocksCEO
- Highest education
- MBA, Leadership · The University of Chicago Booth School of Business
Investors · 8
- AlexandriaFund
- CanaanFund
- Versant VenturesFund
- MPM CapitalFund
- Zenyaku KogyoFund
Patents
Patent filings225
Focus: Broadly neutralizing monoclonal antibodies targeting HIV-1 envelope glycoprotein (gp120/gp41)
CPC C07K16/114, C07K16/108, C07K16/1145Technology
- PHP
- jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 17 (previous snapshot 90)
- Recorded funding
- US$211.00m · Series C · Sep 2020
- Founded
- 2016 · about 10 years old
- Stage
- Public
- Focus
- Drugs, Diversified
Funding over time
US$211.00m across 4 disclosed equity rounds
Darker bars = larger roundsFounders · 1
Peter ThompsonCo-Founder
Investors · 15
- AlexandriaFund
- Boxer CapitalFund
- CelgeneFund
- Colt VenturesFund
- EcoR1Fund
Patents
Patent filings143
Focus: Develops small‑molecule kinase inhibitors and antibody‑drug conjugates for oncology targets.
CPC C07D401/12, A61K47/6803, C07D401/14Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Software
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 15 (previous snapshot 10)
- Recorded funding
- US$19.82m · Seed · Jul 2024
- Founded
- 2020 · about 6 years old
- Stage
- Seed
- Focus
- Research & development, Drug discovery, Proteomics, Research assays
Funding over time
US$19.82m across 4 disclosed equity rounds
Darker bars = larger roundsFounders · 2
Alex FederationCo-Founder & CEO
- Highest education
- Harvard University
Lindsay PinoCo-Founder and CTO
Investors · 7
- BoxOne VenturesFund
- Fifty YearsFund
- FundersClubFund
- NFXFund
- Two Bear CapitalFund
- Y CombinatorFund
Team & hiring signals
LinkedIn headcount2911-50
LinkedIn followers5,684
Open roles2of 2 tracked · last posted Jan 2026
- Hiring: Research Associate II · Seattle
- Internship: Business Development Intern · Seattle
Recent company signals
- Partnership Partnership with Lilly TuneLab
Patents
Patent filings27
Focus: Automotive interior storage and organization systems for floor and cargo compartments
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Hardware
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Physical commerce
- Team size
- 13
- Recorded funding
- US$23.17m · Series A · Sep 2019
- Founded
- 2002 · about 24 years old
- Stage
- Public
- Focus
- Medical devices, Therapies, Radiation therapy, Radiowave therapy
Funding over time
US$23.17m across 6 disclosed equity rounds
Darker bars = larger roundsFounders · 3
Bennett M. ButtersFounder
Kenneth FergusonCo-Founder & CSO
Xavier A. FigueroaCo-Founder & Director
Team & hiring signals
LinkedIn headcount1311-50
LinkedIn followers901
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Fee-for-service
- Team size
- 13 (previous snapshot 15)
- Recorded funding
- US$7.79m · Seed · Jul 2021
- Founded
- 2018 · about 8 years old
- Stage
- Seed
- Focus
- Drugs, Pan cancer, Nanoenabled products, Life science
Funding over time
US$7.79m across 3 disclosed equity rounds
Darker bars = larger roundsFounders · 3
John LewisCo-Founder
- Highest education
- Nanotechnology · Scripps Research
Gary HudsonCo-Founder
Matthew ScholzCo-Founder & CEO
- Highest education
- Bachelor's of Science · University of Washington
Team & hiring signals
LinkedIn headcount92-10
LinkedIn followers976
Patents
Patent filings4
Focus: In vivo CAR‑T gene therapy delivery for cancer immunotherapy
CPC A61K48/0033, C12N15/88Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Life sciences tech · 32
32 life sciences companies in Seattle work in life sciences tech. Shown: the best-documented.
Life sciences techProvider of healthcare data platform for learning services
Revenue modelSubscription
Founders · 2
Jay NanduriCo-Founder & CTO
Terry MyersonCo-Founder & CEO
Life sciences techManufacturer of drugs for multiple therapautic areas
Revenue modelSubscription
Leadership · 1
Nicholas GeisseCEO
Life sciences techProvider of software for 3D visualization of images
Revenue modelSubscription
Leadership · 2
Nicholas RederCEO
Nicholas RederCEO
Life sciences techDeveloper of cloud-based protein-modelling software for drug discovery
Revenue modelSubscription
Founders · 3
Lucas NivonCo-Founder & CEO
Yifan SongCo-Founder & CSO
Javier CastellanoCo-Founder & CTO
Healthcare itProvider of cloud-based laboratory management software for research labs
Revenue modelSubscription
Founders · 2
Jin ChoeCo-Founder & CTO
Jacob LeeCo-Founder & CEO
OncologyProvider of drug discovery platform for gene regulators
Revenue modelSubscription
Founders · 2
Alex FederationCo-Founder & CEO
Lindsay PinoCo-Founder and CTO
Clinical labs itDeveloper of cloud-based imaging and sample management platform
Revenue modelSubscription
Founder · 1
Jaron NixCo-Founder & CTO
Life sciences techDeveloper of computational drug discovery platform
Revenue modelSubscription
Founders · 2
Raphael GottardoCo-Founder
Greg FinakCo-Founder
Healthcare itImaging solutions for digital pathology and publishing sectors
Revenue modelSubscription
Founder · 1
Jason SwedlowFounder & CEO
Life sciences techAI-powered key opinion leader management system for medical affairs professionals
Revenue modelAdvertising / Commission on transaction
Founders · 2
Gordon SilvermanCo-Founder
Mahek ChhatrapatiCo-Founder & CEO
GenomicsProvider of AI-generated gene expression data for biological research purposes
Revenue modelSubscription
Founders · 2
Robert BradleyCo-Founder
Jeff LeekCo-Founder & CEO
OncologyDeveloper of de novo protein therapies for complex diseases treatment
Revenue modelPhysical commerce / Subscription
Founders · 4
Javier CastellanosCo-Founder & CTO
Bill ArthurCo-Founder & CEO
Hector RinconCo-Founder & CSO
Matthew BickCo-Founder & CEO
SaaSSocial impactSoftware
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 250 (previous snapshot 264)
- Recorded funding
- US$515.00m · Series C · Jan 2025
- Founded
- 2020 · about 6 years old
- Stage
- Series C
- Focus
- Provider, Administrative solutions, Data management, Clinical data management
Funding over time
US$515.00m across 3 disclosed equity rounds
Darker bars = larger roundsFounders · 2
Jay NanduriCo-Founder & CTO
- Highest education
- Master's of business administration in management · The Wharton School
Terry MyersonCo-Founder & CEO
- Highest education
- Mechanical Engineering · Duke University
Investors · 9
- CommonSpiritFund
- IlluminaFund
- NorthwellFund
- Trinity HealthFund
- Advocate HealthFund
Team & hiring signals
LinkedIn headcount475201-500
LinkedIn followers105,153
Earlier recorded team2502023, a different source
Open roles7of 46 tracked · last posted Sep 2026
Patents
Patent filings17
Focus: Privacy-preserving health data integration, normalization, and analytics using de‑identification and ontology matching
CPC G16H10/60, G06F21/6254, G06F16/116Technology
- Azure
- PHP
- MySQL
- Cloudflare
- HubSpot
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
SaaSSoftwareHas made acquisitions
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 47 (previous snapshot 49)
- Recorded funding
- US$26.00m · Series B · Dec 2025
- Founded
- 2015 · about 11 years old
- Stage
- Series B
- Focus
- Ai based, Cheminformatics, Drug discovery, Lead discovery
Funding over time
US$26.00m across 3 disclosed equity rounds
Darker bars = larger roundsLeadership · 1
Nicholas GeisseCEO
- Highest education
- PhD · University of Cambridge
Investors · 5
- DSFund
- Dynamk CapitalFund
- UTC InvestmentFund
- Dream CISFund
Team & hiring signals
LinkedIn headcount5711-50
LinkedIn followers9,734
Earlier recorded team472022, a different source
Technology
- AWS
- Angular
- TypeScript
- Cloudflare
- HubSpot
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
SaaSSoftware
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 27 (previous snapshot 15)
- Recorded funding
- US$7.58m · Series A · Mar 2024
- Founded
- 2014 · about 12 years old
- Stage
- Series A
- Focus
- Research & development, Image analysis, Super resolution microscopy, Pathology
Funding over time
US$7.58m across 2 disclosed equity rounds
Darker bars = larger roundsLeadership · 2
Nicholas RederCEO
- Highest education
- MD, Medicine · LOYOLA UNIVERSITY CHICAGO
Nicholas RederCEO
- Highest education
- MD, Medicine · LOYOLA UNIVERSITY CHICAGO
Investors · 1
- Dynamk CapitalFund
Team & hiring signals
LinkedIn headcount3211-50
LinkedIn followers6,309
Technology
- Angular
- TypeScript
- Cloudflare
- HubSpot
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
SaaSSoftwareHas made acquisitions
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 23
- Recorded funding
- US$31.99m · Series B · Feb 2024
- Founded
- 2014 · about 12 years old
- Stage
- Series B
- Focus
- Research & development, Drug discovery, Proteomics
Funding over time
US$31.99m across 7 disclosed equity rounds
Darker bars = larger roundsFounders · 3
Lucas NivonCo-Founder & CEO
Yifan SongCo-Founder & CSO
- Highest education
- Doctorates in physics · Ccny School Of Education
Javier CastellanoCo-Founder & CTO
Investors · 10
- Agent CapitalFund
- Alumni VenturesFund
- Medtech WingsFund
- OrbimedFund
- The W FundFund
- Trinity VenturesFund
Team & hiring signals
LinkedIn headcount1711-50
LinkedIn followers4,724
Earlier recorded team232022, a different source
Technology
- PHP
- MySQL
- WordPress
- jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
SaaSSoftware
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 16 (previous snapshot 16)
- Recorded funding
- US$7.22m · Seed · May 2023
- Founded
- 2017 · about 9 years old
- Stage
- Seed
- Focus
- Research & development, Laboratory management, Lims, Pathology
Funding over time
US$7.22m across 3 disclosed equity rounds
Darker bars = larger roundsFounders · 2
Jin ChoeCo-Founder & CTO
Jacob LeeCo-Founder & CEO
- Highest education
- Master's in biomedical engineering · University Of Washington College Of Engineering
Investors · 6
- CanaanFund
DefyFund
LDV PartnersFund
Underdog LabsFund
Team & hiring signals
LinkedIn headcount611-50
LinkedIn followers2,445
Recent company signals
- Launch Launched Genemod AI Agent (AI for Science)
- Award G2 Summer 2026 reports
- Award 13 G2 Best Software Awards — Spring 2026
Technology
- AWS
- React
- Segment
- Amazon S3
- CloudFront
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Software
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 15 (previous snapshot 10)
- Recorded funding
- US$19.82m · Seed · Jul 2024
- Founded
- 2020 · about 6 years old
- Stage
- Seed
- Focus
- Research & development, Drug discovery, Proteomics, Research assays
Funding over time
US$19.82m across 4 disclosed equity rounds
Darker bars = larger roundsFounders · 2
Alex FederationCo-Founder & CEO
- Highest education
- Harvard University
Lindsay PinoCo-Founder and CTO
Investors · 7
- BoxOne VenturesFund
- Fifty YearsFund
- FundersClubFund
- NFXFund
- Two Bear CapitalFund
- Y CombinatorFund
Team & hiring signals
LinkedIn headcount2911-50
LinkedIn followers5,684
Open roles2of 2 tracked · last posted Jan 2026
- Hiring: Research Associate II · Seattle
- Internship: Business Development Intern · Seattle
Recent company signals
- Partnership Partnership with Lilly TuneLab
Patents
Patent filings27
Focus: Automotive interior storage and organization systems for floor and cargo compartments
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
SaaSSoftware
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 13 (previous snapshot 21)
- Recorded funding
- US$8.46m · Series A · Apr 2022
- Founded
- 2003 · about 23 years old
- Stage
- Series A
- Focus
- Pathology, Pre analytical, Sample management, Provider
Funding over time
US$8.46m across 2 disclosed equity rounds
Darker bars = larger roundsFounders · 1
Jaron NixCo-Founder & CTO
- Highest education
- Master's in economics · University Of Alabama, Manderson Graduate School Of Business
Investors · 8
- James WattAngel
- David JohnsonAngel
- Peter FaroniAngel
- Sidney TaurelAngel
Team & hiring signals
LinkedIn headcount1611-50
LinkedIn followers1,346
Patents
Patent filings15
Focus: Automated computational microscopy for point-of-care pathology imaging and analysis
CPC G02B21/367, G01N21/4788, G06V20/698Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Artificial IntelligenceSoftware
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 12
- Recorded funding
- US$32.00m · Series A · Jul 2022
- Founded
- 2021 · about 5 years old
- Stage
- Series A
- Focus
- Research & development, Drug discovery, Cheminformatics, Lead discovery
Funding over time
US$32.00m across 2 disclosed equity rounds
Darker bars = larger roundsFounders · 2
Raphael GottardoCo-Founder
- Highest education
- PhD, Statistics · University of Washington
Greg FinakCo-Founder
- Highest education
- Doctorates in biochemistry · Mcgill University
Investors · 8
- AlexandriaFund
- Duke UniversityFund
- M12Fund
- OCV PartnersFund
- VulcanFund
Team & hiring signals
LinkedIn headcount2911-50
LinkedIn followers2,851
Earlier recorded team122021, a different source
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Software
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 12 (previous snapshot 11)
- Recorded funding
- US$800k · Seed · Feb 2015
- Founded
- 2005 · about 21 years old
- Stage
- Seed
- Focus
- Research & development, Image analysis, Digital pathology, Pathology
Founders · 1
Jason SwedlowFounder & CEO
- Highest education
- Doctorates in biophysics · University Of California, San Francisco
Investors · 1
Z5 CatalystFund
Team & hiring signals
LinkedIn headcount1111-50
LinkedIn followers635
Recent company signals
- Partnership Partnership with Image Cooperative
Technology
- jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Advertising, Commission on transaction, Subscription
- Team size
- 8
- Recorded funding
- US$20k · Seed · Jan 2022
- Founded
- 2022 · about 4 years old
- Stage
- Seed
- Focus
- Research & development, Drug informatics, Scientific literature, Online search portals
Founders · 2
Gordon SilvermanCo-Founder
- Highest education
- MBA · Duke University
Mahek ChhatrapatiCo-Founder & CEO
- Highest education
- MBA · Duke University
Investors · 1
- TechstarsFund
Team & hiring signals
Open roles0of 2 tracked · last posted Jan 2025
Technology
- AWS
- React
- Cloudflare
- Amazon S3
- Tailwind CSS
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Artificial IntelligenceSoftware
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- Not available
- Recorded funding
- US$10.00m · Series A · Sep 2025
- Founded
- 2023 · about 3 years old
- Stage
- Series A
- Focus
- Research & development, Drug discovery, Genomics, Genomics services
Founders · 2
Robert BradleyCo-Founder
- Highest education
- The University of California
Jeff LeekCo-Founder & CEO
- Highest education
- University of Washington
Investors · 1
Team & hiring signals
LinkedIn headcount2111-50
LinkedIn followers1,899
Recent company signals
- Award AI Innovation of the Year — GeekWire
Technology
- Cloudflare
- HubSpot
- Webflow
- jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Software
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Physical commerce, Subscription
- Team size
- Not available
- Recorded funding
- US$12.70m · Seed · Nov 2025
- Founded
- 2023 · about 3 years old
- Stage
- Seed
- Focus
- Autoimmune diseases, Diversified, Drug discovery, Drugs
Founders · 4
Javier CastellanosCo-Founder & CTO
- Highest education
- Doctorates in biochemistry · University Of Washington
Bill ArthurCo-Founder & CEO
Hector RinconCo-Founder & CSO
Matthew BickCo-Founder & CEO
Investors · 8
- AlexandriaFund
- ArgonauticFund
- Pack VenturesFund
- TakedaFund
- Columbus Venture PartnersFund
Team & hiring signals
LinkedIn headcount2411-50
LinkedIn followers1,298
Technology
- PHP
- MySQL
- Cloudflare
- WordPress
- Bootstrap
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Genomics · 32
32 life sciences companies in Seattle work in genomics. Shown: the best-documented.
Healthcare booking platformsProvider of direct-to-consumer genetic testing.
Revenue modelSubscription
Founders · 3
Clayton LewisCo-Founder & CEO
Nathan PriceCo-Founder
Leroy HoodCo-Founder
Rare diseasesDeveloper of RNA-targeted therapies intended to treat multiple diseases
Revenue modelSubscription
Founders · 2
Prashant MaliCo-Founder
Francois VigneaultCo-Founder & CEO
Life sciences platforms and toolsDeveloper of RNA-sequencing solution-based transcriptome kit to analyze health data
Revenue modelSubscription
Founders · 2
Geoff KrummelCo-Founder
Alex RosenbergCo-Founder & CEO
GenomicsDeveloper of cell and gene therapy by using the epigenomic platform
Revenue modelSubscription
Founders · 2
Akira MatsunoCo-Founder, President & CFO
Daniel McHughCo-Founder
GenomicsDeveloper of DNA sequencing technology to identify genomic mutations
Revenue modelSubscription
Founders · 2
Mike SchmittCo-Founder
Jesse SalkCo-Founder
GenomicsDeveloper of drugs for neurodegenerative disease based on genetic screening, and multi-omics approach
Revenue modelSubscription
Founders · 2
Ian PeikonCo-Founder
Andrew DervanCo-Founder
GenomicsDeveloper of technologies for the analysis of rare and single cells in the blood
Revenue modelSubscription
Leadership · 1
Joseph VictorPresident & CEO
Life sciences platforms and toolsProvider of laboratory and computational services and products
Revenue modelSubscription
Founders · 2
Shawn SullivanCo-Founder
Ivan LiachkoCo-Founder
GenomicsProvider of EHR integrated solutions to healthcare systems
Revenue modelFee-for-service
Leadership · 1
Andrew UryCEO and Chairman
GenomicsManufacturer of microbiome cap device for medical treatment
Revenue modelFee-for-service
Founders · 2
Thomas LendvayCo-Founder & Chief Medical Officer
Kathleen LendvayCo-founder, President and COO
Women healthProvider of DNA and hormone analysis based birth control optimization kits
Revenue modelSubscription
Founder · 1
Elizabeth RuzzoFounder & CEO
Life sciences platforms and toolsProvider of stem cell technology that converts mature skin cells into stem cells
Revenue modelPhysical commerce / Subscription
Founder · 1
Andranik Andrew AprikyanEVP, CSO and Co-Founder
Consumer
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 160
- Recorded funding
- US$53.60m · Series C · Jun 2017
- Founded
- 2014 · about 12 years old
- Stage
- Series C
- Focus
- Applied genomics, Consumer genomics, Health and wellness, Diagnostics
Funding over time
US$49.60m across 2 disclosed equity rounds
Darker bars = larger roundsFounders · 3
Clayton LewisCo-Founder & CEO
- Highest education
- BA, Business Administration · University of Washington
Nathan PriceCo-Founder
- Highest education
- Doctorates in bioengineering · Uc San Diego
Leroy HoodCo-Founder
- Highest education
- MD · Johns Hopkins Medicine
Investors · 3
- MaveronFund
- Polaris PartnersFund
Patents
Patent filings2
Focus: Predictive health analytics linking dynamic biomarkers to disease risk
CPC G16B40/00, G16B40/10Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Software
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 117 (previous snapshot 159)
- Recorded funding
- US$147.50m · Series B · Jul 2021
- Founded
- 2018 · about 8 years old
- Stage
- Series B
- Focus
- Drugs, Neurodegenerative, Diversified, Applied genomics
Funding over time
US$147.50m across 2 disclosed equity rounds
Darker bars = larger roundsFounders · 2
Prashant MaliCo-Founder
Francois VigneaultCo-Founder & CEO
- Highest education
- Master's of science in biology · Université Laval
Investors · 6
- Decheng CapitalFund
- Willett AdvisorsFund
- Breton Capital VenturesFund
Team & hiring signals
LinkedIn headcount3151-200
LinkedIn followers13,381
Earlier recorded team1172022, a different source
Recent company signals
- Partnership Partnership with VectorY Therapeutics
Patents
Patent filings175
Focus: Engineering AAV vectors and guide RNAs for enhanced gene‑therapy delivery and expression.
CPC C12N15/113, C12N15/86, C07K14/005Technology
- PHP
- MySQL
- Cloudflare
- WordPress
- jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Has made acquisitions
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 107 (previous snapshot 110)
- Recorded funding
- US$100.26m · Series C · Dec 2023
- Founded
- 2018 · about 8 years old
- Stage
- Series C
- Focus
- Enabling technologies, Kits and reagents, Detection and quantification, Research reagents and kits
Funding over time
US$100.26m across 5 disclosed equity rounds
Darker bars = larger roundsFounders · 2
Geoff KrummelCo-Founder
Alex RosenbergCo-Founder & CEO
- Highest education
- BA · Washington University in St. Louis
Investors · 7
- LogosFund
- Marshall WaceFund
- Sahsen VenturesFund
- Soleus CapitalFund
- Saras CapitalFund
Team & hiring signals
LinkedIn headcount13551-200
LinkedIn followers26,097
Open roles4of 11 tracked · last posted Jul 2026
Technology
- AWS
- PHP
- MySQL
- Cloudflare
- Sentry
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 89 (previous snapshot 105)
- Recorded funding
- US$222.41m · Series B · Mar 2023
- Founded
- 2009 · about 17 years old
- Stage
- Series B
- Focus
- Applied genomics, Clinical genomics, Therapeutics
Funding over time
US$222.41m across 2 disclosed equity rounds
Darker bars = larger roundsFounders · 2
Akira MatsunoCo-Founder, President & CFO
Daniel McHughCo-Founder
- Highest education
- Master's of Science · Stanford University
Investors · 7
- HevolutionFund
- YosemiteFund
Team & hiring signals
LinkedIn headcount6251-200
LinkedIn followers24,246
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 70 (previous snapshot 110)
- Recorded funding
- US$84.02m · Series B · Jun 2023
- Founded
- 2015 · about 11 years old
- Stage
- Series B
- Focus
- Genome informatics, Sequence analysis
Funding over time
US$84.02m across 5 disclosed equity rounds
Darker bars = larger roundsFounders · 2
Mike SchmittCo-Founder
- Highest education
- Doctor of Philosophy, Biochemistry · University of Washington
Jesse SalkCo-Founder
- Highest education
- Doctor of medicine in molecular biology · University Of Washington - School Of Medicine
Investors · 7
- AlexandriaFund
- S32Fund
- Sahsen VenturesFund
- Soleus CapitalFund
Team & hiring signals
LinkedIn headcount1351-200
LinkedIn followers5,810
Earlier recorded team702022, a different source
Technology
- PHP
- MySQL
- Nginx
- Cloudflare
- HubSpot
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 60 (previous snapshot 49)
- Recorded funding
- US$96.00m · Series A · Nov 2022
- Founded
- 2020 · about 6 years old
- Stage
- Series A
- Focus
- Applied genomics, Clinical genomics, Therapeutics, Drugs
Founders · 2
Ian PeikonCo-Founder
Andrew DervanCo-Founder
Investors · 7
- AlexandriaFund
- EvotecFund
- Lux CapitalFund
- The Column GroupFund
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 54
- Recorded funding
- US$114.33m · Series C · Jun 2024
- Founded
- 2009 · about 17 years old
- Stage
- Series C
- Focus
- Enabling technologies, Kits and reagents, Detection and quantification, Research reagents and kits
Funding over time
US$114.33m across 6 disclosed equity rounds
Darker bars = larger roundsLeadership · 1
Joseph VictorPresident & CEO
Investors · 9
- 5AM VenturesFund
- AgilentFund
- F-Prime CapitalFund
- LogosFund
- Bill BurkothAngel
Team & hiring signals
LinkedIn headcount6451-200
LinkedIn followers6,444
Earlier recorded team542022, a different source
Open roles1of 1 tracked · last posted Mar 2026
Patents
Patent filings266
Focus: Multiplexed fluorescence microscopy with spectral crosstalk reduction and angle-tuned illumination.
CPC B01L3/50215, B01L3/5021, G02B21/26Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 19 (previous snapshot 34)
- Recorded funding
- US$5.75m · Series A · Mar 2023
- Founded
- 2015 · about 11 years old
- Stage
- Series A
- Focus
- Research services, Genomics, Next generation sequencing (ngs), Enabling technologies
Funding over time
US$5.75m across 2 disclosed equity rounds
Darker bars = larger roundsFounders · 2
Shawn SullivanCo-Founder
Ivan LiachkoCo-Founder
- Highest education
- Doctorates in genetics · Cornell University
Investors · 2
Team & hiring signals
LinkedIn headcount1411-50
LinkedIn followers6,752
Earlier recorded team192021, a different source
Patents
Patent filings22
Focus: Genomic sequencing analytics, chromosome conformation capture, and lysin-based antibacterial therapeutics.
CPC G16B20/20, C12N15/1006, C12Q1/6806Technology
- PHP
- MySQL
- HubSpot
- WordPress
- jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Fee-for-service
- Team size
- 11 (previous snapshot 28)
- Recorded funding
- US$11.77m · Series B · Dec 2022
- Founded
- 2012 · about 14 years old
- Stage
- Series B
- Focus
- Applied genomics, Clinical genomics, Diagnostics, Sequencing-based
Funding over time
US$11.77m across 4 disclosed equity rounds
Darker bars = larger roundsLeadership · 1
Andrew UryCEO and Chairman
Investors · 1
Team & hiring signals
LinkedIn headcount2111-50
LinkedIn followers1,688
Earlier recorded team112022, a different source
Recent company signals
- Partnership Partnership with GDE
Patents
Patent filings15
Focus: Cloud-based health data services and B‑cell mediated cell therapies for tissue regeneration
CPC C12N5/0635, G16H10/60, A61L31/005Mobile apps
- My ActX Genomic ProfileMedical · 49 installs · updated 2026-04-07
Technology
- AWS
Ruby On Rails- Bootstrap
- jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Social impactSoftwareHardware
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Fee-for-service
- Team size
- 10
- Recorded funding
- US$2.50m · Seed · Jun 2021
- Founded
- 2017 · about 9 years old
- Stage
- Seed
- Focus
- Applied genomics, Consumer genomics, Microbiomics, Medical devices
Funding over time
US$2.50m across 3 disclosed equity rounds
Darker bars = larger roundsFounders · 2
Thomas LendvayCo-Founder & Chief Medical Officer
Kathleen LendvayCo-founder, President and COO
- Highest education
- Bachelor's in economics · Rice University
Team & hiring signals
LinkedIn headcount162-10
LinkedIn followers436
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Consumer
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 10 (previous snapshot 15)
- Recorded funding
- US$2.65m · Seed · Apr 2021
- Founded
- 2019 · about 7 years old
- Stage
- Seed
- Focus
- In vitro diagnostic tests, Fertility, Pregnancy, Applied genomics
Funding over time
US$2.65m across 2 disclosed equity rounds
Darker bars = larger roundsFounders · 1
Elizabeth RuzzoFounder & CEO
Investors · 11
- ASCENDFund
- Concrete RoseFund
- Lux CapitalFund
- M13 CompanyFund
- Y CombinatorFund
- Anne WojcickiAngel
Team & hiring signals
LinkedIn headcount82-10
LinkedIn followers2,569
Technology
- AWS
- PHP
- MySQL
- Cloudflare
- HubSpot
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Physical commerce, Subscription
- Team size
- 5
- Recorded funding
- US$3.35m · Seed · Jun 2018
- Founded
- 2008 · about 18 years old
- Stage
- Seed
- Focus
- Applied genomics, Clinical genomics, Therapeutics, Research services
Funding over time
US$3.35m across 3 disclosed equity rounds
Darker bars = larger roundsFounders · 1
Andranik Andrew AprikyanEVP, CSO and Co-Founder
- Highest education
- Master's of science in chemistry · Lomonosov Moscow State University (Msu)
Team & hiring signals
LinkedIn headcount42-10
LinkedIn followers184
Patents
Patent filings50
Focus: Functionalized nanoparticles for intracellular gene delivery, editing, and cell reprogramming
CPC A61K47/6929, B60R22/3413, G01N33/54353Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Explore more lists: nearby cities and other sectors in Seattle
122 more company lists you can search, plus the Radar directory pages for each place.
Life sciences in nearby cities
- Oakland33 life sciences companiesExplore on Radar
- San Jose110 life sciences companiesExplore on Radar
- Palo Alto165 life sciences companiesExplore on Radar
- Mountain View112 life sciences companiesExplore on Radar
- Santa Clara70 life sciences companiesExplore on Radar
- Sunnyvale123 life sciences companiesExplore on Radar
- San Mateo49 life sciences companiesExplore on Radar
- Redwood City107 life sciences companiesExplore on Radar
- Berkeley109 life sciences companiesExplore on Radar
- Santa Monica35 life sciences companiesExplore on Radar
- San Diego847 life sciences companiesExplore on Radar
- Los Angeles286 life sciences companiesExplore on Radar
Life sciences in other US cities
- New York City665 life sciences companiesExplore on Radar
- Chicago205 life sciences companiesExplore on Radar
- Austin221 life sciences companiesExplore on Radar
- Boston537 life sciences companiesExplore on Radar
- Miami106 life sciences companiesExplore on Radar
- Seattle247 life sciences companiesExplore on Radar
- Denver82 life sciences companiesExplore on Radar
- Atlanta133 life sciences companiesExplore on Radar
- Houston240 life sciences companiesExplore on Radar
- Dallas104 life sciences companiesExplore on Radar
- Philadelphia207 life sciences companiesExplore on Radar
- Washington435 life sciences companiesExplore on Radar
Other sectors in Seattle
- Enterprise Applications Companies in Seattle, United States 832
- Business Services Companies in Seattle, United States 599
- Consumer Companies in Seattle, United States 530
- High Tech Companies in Seattle, United States 376
- Retail Companies in Seattle, United States 323
- HealthTech Companies in Seattle, United States 305
- Real Estate and Construction Companies in Seattle, United States 277
- Enterprise Infrastructure Companies in Seattle, United States 254
- FinTech Companies in Seattle, United States 243
- Media & Entertainment Companies in Seattle, United States 236
- Investment Industry Companies in Seattle, United States 222
- Consumer Goods Companies in Seattle, United States 217
- MarketingTech Companies in Seattle, United States 198
- Healthcare Companies in Seattle, United States 180
- Food and Agriculture Companies in Seattle, United States 176
- Marketing Services Companies in Seattle, United States 149
- Native AI Companies in Seattle, United States 144
- HRTech Companies in Seattle, United States 138
- Artificial Intelligence Companies in Seattle, United States 137
- Financial Services Companies in Seattle, United States 132
- Healthcare IT Companies in Seattle, United States 125
- Gaming Companies in Seattle, United States 124
- IT Services Companies in Seattle, United States 123
- Education Companies in Seattle, United States 112
- Real Estate and Construction Tech Companies in Seattle, United States 110
- Cybersecurity Companies in Seattle, United States 108
- Sustainability Tech Companies in Seattle, United States 104
- Venture Capital Funds Companies in Seattle, United States 100
- Food and Agriculture Tech Companies in Seattle, United States 97
- Enterprise Software Companies in Seattle, United States 93
- Mobile Companies in Seattle, United States 86
- EdTech Companies in Seattle, United States 85
- Internet of Things - Industry Applications Companies in Seattle, United States 82
- Transportation and Logistics Tech Companies in Seattle, United States 81
- Auto Tech Companies in Seattle, United States 77
- Nonprofits Companies in Seattle, United States 77
- Travel and Hospitality Tech Companies in Seattle, United States 74
- Energy Tech Companies in Seattle, United States 74
- SaaS Companies in Seattle, United States 73
- Investment Tech Companies in Seattle, United States 71
- Blockchain Technology Companies in Seattle, United States 70
- Sales Force Automation Companies in Seattle, United States 66
- Foundations Companies in Seattle, United States 65
- PC & Console Gaming Companies in Seattle, United States 65
- Travel and Hospitality Companies in Seattle, United States 65
- Environment Tech Companies in Seattle, United States 63
- Environment Companies in Seattle, United States 62
- E-Commerce Enablers Companies in Seattle, United States 60
- Unbundling of Craigslist Companies in Seattle, United States 56
- Enterprise Collaboration Companies in Seattle, United States 56
- Logistics Tech Companies in Seattle, United States 53
- Social Platforms Companies in Seattle, United States 52
- Life Sciences Platforms and Tools Companies in Seattle, United States 52
- Aerospace, Maritime and Defense Tech Companies in Seattle, United States 50
- Fashion Tech Companies in Seattle, United States 50
- Management Consulting Services Companies in Seattle, United States 50
- Local Services Companies in Seattle, United States 48
- Mobile Gaming Companies in Seattle, United States 47
- Oncology Companies in Seattle, United States 47
- Sports Tech Companies in Seattle, United States 47
- Food & Beverage Products Companies in Seattle, United States 46
- K-12 EdTech Companies in Seattle, United States 46
- Big Data Analytics Companies in Seattle, United States 44
- Food Service Chains Companies in Seattle, United States 44
- Finance & Accounting Tech Companies in Seattle, United States 43
- Auto Companies in Seattle, United States 42
- Energy Companies in Seattle, United States 42
- Fitness & Wellness Tech Companies in Seattle, United States 42
- Real Estate Brokers Companies in Seattle, United States 42
- Real Estate & Infrastructure Developers Companies in Seattle, United States 42
- Transportation and Logistics Companies in Seattle, United States 42
- Internet First Media Companies in Seattle, United States 41
- Private Equity Funds Companies in Seattle, United States 40
- HR Services Companies in Seattle, United States 40
- AI Infrastructure Companies in Seattle, United States 39
- B2C E-Commerce Companies in Seattle, United States 39
- Life Sciences Tech Companies in Seattle, United States 39
- Genomics Companies in Seattle, United States 38
- Virtual Reality Companies in Seattle, United States 38
- Food Tech Companies in Seattle, United States 37
- Legal Services Companies in Seattle, United States 37
- Online Photos Companies in Seattle, United States 37
- Wearable Technology Companies in Seattle, United States 37
- IT Operations Companies in Seattle, United States 36
- Telecom Companies in Seattle, United States 36
- Data as a Service Companies in Seattle, United States 36
- AdTech Companies in Seattle, United States 36
- Application Development Tools Companies in Seattle, United States 35
- Auto Retail & Aftersales Companies in Seattle, United States 35
- Business Intelligence Companies in Seattle, United States 35
- Industrial Goods and Manufacturing Companies in Seattle, United States 35
- Online Travel Companies in Seattle, United States 35
- GRC Software Companies in Seattle, United States 34
- Legal Tech Companies in Seattle, United States 34
- Semiconductors Companies in Seattle, United States 34
- Services for Healthcare Providers Companies in Seattle, United States 34
- Cryptocurrencies Companies in Seattle, United States 33
- Vertical Business Intelligence Companies in Seattle, United States 33
No list matches. Try a shorter word.